 |
|
|
|
ONCOLOGÍA TRANSLACIONAL
|
|
Publicaciones 2014
|
DOCUMENTACIÓN |
F.I. |
CUARTIL |
|
Custodio, A.; Moreno-Rubio, J.; Aparicio, J.; Gallego-Plazas, J.; Yaya, R.; Maurel, J.; Higuera, O.; Burgos, E.; Ramos, D.; Calatrava, A.; Andrada, E.; López, R.; Moreno, V.; Madero, R.; Cejas, P.; Feliú, J. Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. ANNALS OF ONCOLOGY. 2014; 25(2): 398-403. Artículo. |
7,04 |
D1 |
|
Barnadas, A.; Mansó, L.; de la Piedra, C.; Meseguer, C.; Crespo, C.; Gómez, P.; Calvo, L.; Martínez, P.; Ruiz-Borrego, M.; Perello, A.; Antón, A.; Codés, M.; Margeli, M.; Murias, A.; Salvador, J.; Seguí, M. A.; de Juan, A.; Gavila, J.; Luque, M.; Pérez, D.; Zamora, P.; Arizcuma, A.; Chacón, J. I.; Heras, L.; Martín-Fernández, M.; Mahillo-Fernández, I.; Tusquets, I. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study). BONE. 2014; 68: 32-40. Artículo. |
3,973 |
Q2 |
|
Johnson, N.; Dudbridge, F.; Orr, N.; Gibson, L.; Jones, M. E.; Schoemaker, M. J.; Folkerd, E. J.; Haynes, B. P.; Hopper, J. L.; Southey, M. C.; Dite, G.S.; Apicella, C.; Schmidt, M. K.; Broeks, A.; Van’t Veer, L. J.; Atsma, F.; Muir, K.; Lophatananon, A.; Fasching, P. A.; Beckmann, M. W.; Ekici, A.B.; Renner, S. P.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Burwinkel, B.; Marme, F.; Schneeweiss, A.; Sohn, C.; Guenel, P.; Truong, T.; Cordina, E.; Menegaux, F.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Milne, R.; Zamora, M. P.; Perez, J. I. A.; Benítez, J.; Bernstein, L.; Antón-Culver, H.; Ziogas, A.; Dur, C. C.; Brenner, H.; Muller, H.; Arndt, V.; Dieffenbach, A. K.; Meindl, A.; Heil, J.; Bartram, C. R.; Schmutzler, R. K.; Brauch, H.; Justenhoven, C.; Ko, Y. D.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Matsuo, K.; Dork, T.; Bogdanova, N. V.; Antonenkova, N. N.; Lindblom, A.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Chenevix-Trench, G.; Beesley, J.; Wu, A. H.; Van den Berg, D.; Tseng, C. C.; Lambrechts, D.; Smeets, D.; Neven, P.; Wildiers, H.; Chang-Claude, J.; Rudolph, A.; Nickels, S.; Flesch-Janys, D.; Radice, P.; Peterlongo, P.; Bonanni, B.; Pensotti, V.; Couch, F. J.; Olson, J. E.; Wang, X. S.; Fredericksen, Z.; Pankratz, V. S.; Giles, G. G.; Severi, G.; Baglietto, L.; Haiman, C.; Simard, J.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Soucy, P.; Teo, S.; Yip, C. H.; Phuah, S. Y.; Cornes, B. K.; Kristensen, V. N.; Alnaes, G. G.; Borresen-Dale, A. L.; Zheng, W.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Devillee, P.; Figueroa, J.; Chanock, S. J.; Lissowska, J.; Sherman, M. E.; Hall, P.; Schoof, N.; Hooning, M.; Hollestelle, A.; Oldenburg, R. A.; Tilanus-Linthorst, M.; Liu, J. J.; Cox, A.; Brock, I. W.; Reed, M.W. R.; Cross, S. S.; Blot, W.; Signorello, L. B.; Pharoah, P. D. P.; Dunning, A. M.; Shah, M.; Kang, D.; Noh, D. Y.; Park, S. K.; Choi, J. Y.; Hartman, M.; Miao, H.; Lim, W. Y.; Tang, A.; Hamann, U.; Forsti, A.; Rudiger, T.; Ulmer, H. U.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Sangrajrang, S.; Gaborieau, V.; Brennan, P.; Mckay, J.; Slager, S.; Toland, A. E.; Vachon, C.; Yannoukakos, D.; Shen, C. Y.; Yu, J. C.; Huang, C. S.; Hou, M. F.; González-Neira, A.; Tessier, D. C.; Vincent, D.; Bacot, F.; Luccarini, C.; Dennis, J.; Michailidou, K.; Bolla, M. K.; Wang, J.; Easton, D. F.; García-Closas, M.; Dowsett, M.; Ashworth, A.; Swerdlow, A. J.; Peto, J.; Silva, I. D.; Fletcher, O. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. BREAST CANCER RESEARCH. 2014; 16(3): R51. Artículo. |
5,49 |
Q1 |
|
Zugazagoitía, J.; Pérez-Segura, P.; Manzano, A.; Blanco, I.; Vega, A.; Custodio, A.; Teule, A.; Fachal, L.; Martínez, B.; González-Sarmiento, R.; Cruz-Hernández, J. J.; Chirivella, I.; Garces, V.; Garre, P.; Romero, A.; Caldes, T.; Díaz-Rubio, E.; de la Hoya, M. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. BREAST CANCER RESEARCH AND TREATMENT. 2014; 148(2): 415-421. Artículo. |
3,94 |
Q2 |
|
Kang, Y. K.; Rha, S. Y.; Tassone, P.; Barriuso, J.; Yu, R.; Szado, T.; Garg, A.; Bang, Y. J. A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer. BRITISH JOURNAL OF CANCER. 2014; 111(4): 660-666. Artículo. |
4,836 |
Q1 |
|
Feliú, J.; Salud, A.; Safont, M. J.; García-Girón, C; Aparicio, J.; Vera, R.; Serra, O.; Casado, E.; Jorge, M.; Escudero, P.; Bosch, C.; Bohn, U.; Pérez-Carrión, R.; Carmona, A.; Martínez-Marín, V.; Maurel, J. First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study. BRITISH JOURNAL OF CANCER. 2014; 111(2): 241-248. Artículo. |
4,836 |
Q1 |
|
Agarwal, D.; Pineda, S.; Michailidou, K.; Herranz, J.; Pita, G.; Moreno, L.T.; Alonso, M. R.; Dennis, J.; Wang, Q.; Bolla, M. K.; Meyer, K. B.; Menéndez-Rodríguez, P.; Hardisson, D.; Mendiola, M.; González-Neira, A.; Lindblom, A.; Margolin, S.; Swerdlow, A.; Ashworth, A.; Orr, N.; Jones, M.; Matsuo, K.; Ito, H.; Iwata, H.; Kondo, N.; Hartman, M.; Hui, M.; Lim, W. Y.; Iau, P. T. C.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Kang, D.; Choi, J. Y.; Park, S. K.; Noh, D. Y.; Hopper, J. L.; Schmidt, D. F.; Makalic, E.; Southey, M. C.; Teo, S. H.; Yip, C. H.; Sivanandan, K.; Tay, W. T.; Brauch, H.; Bruning, T.; Hamann, U.; Dunning, A. M.; Shah, M.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Tchatchou, S.; Schmidt, M. K.; Broeks, A.; Rosenberg, E. H.; van’t Veer, L. J.; Fasching, P. A.; Renner, S. P.; Ekici, A. B.; Beckmann, M. W.; Shen, C. Y.; Hsiung, C. N.; Yu, J. C.; Hou, M. F.; Blot, W.; Cai, Q.; Wu, A. H.; Tseng, C. C.; Van Den Berg, D.; Stram, D. O.; Cox, A.; Brock, I. W.; Reed, M. W. R.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Zheng, W.; Deming-Halverson, S.; Shrubsole, M. J.; Long, J.; Shu, X. O.; Lu, W.; Gao, Y. T.; Zhang, B.; Radice, P.; Peterlongo, P.; Manoukian, S.; Mariette, F.; Sangrajrang, S.; Mckay, J.; Couch, F. J.; Toland, A. E.; Yannoukakos, D.; Fletcher, O.; Johnson, N.; Silva, I. D.; Peto, J.; Marme, F.; Burwinkel, B.; Guenel, P.; Truong, T.; Sánchez, M.; Mulot, C.; Bojesen, S. E.; Nordestgaard, B. G.; Flyer, H.; Brenner, H.; Dieffenbach, A. K.; Arndt, V.; Stegmaier, C.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Lambrechts, D.; Yesilyurt, B. T.; Floris, G.; Leunen, K.; Chang-Claude, J.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Wang, X.; Olson, J. E.; Vachon, C.; Purrington, K.; Giles, G. G.; Severi, G.; Baglietto, L.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Simard, J.; Dumont, M.; Goldberg, M. S.; Labreche, F.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; García-Closas, M.; Chanock, S. J.; Lissowska, J.; Figueroa, J. D.; Czene, K.; Eriksson, M.; Humphreys, K.; Darabi, H.; Hooning, M. J.; Kriege, M.; Collee, J. M.; Tilanus-Linthorst, M.; Li, J.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Bogdanova, N.; Dork, T.; Hall, P. Chenevix-Trench, G.; Easton, D. F.; Pharoah, P. D. P.; Arias-Pérez, J. I.; Zamora, P.; Benítez, J.; Milne, R. L. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. BRITISH JOURNAL OF CANCER. 2014; 110(4): 1088-1100. Artículo. |
4,836 |
Q1 |
|
López-Ayllón, B. D.; Moncho-Amor, V.; Abarrategi, A.; de Cáceres, I. I.; Castro-Carpeno, J.; Belda-Iniesta, C.; Perona, R.; Sastre, L. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations. CANCER MEDICINE. 2014; 3(5): 1099-1111. Artículo. |
2,5 |
Q3 |
|
González-Martín, A.; Bover, I.; del Campo, J. M.; Redondo, A.; Vidal, L. SEOM guideline in ovarian cancer 2014. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(12): 1067-1071. Artículo. |
2,077 |
Q3 |
|
Sastre, J.; Argiles, G.; Benavides, M.; Feliú, J.; García-Alfonso, P.; García-Carbonero, R.; Gravalos, C.; Guillén-Ponce, C.; Martínez-Villacampa, M.; Pericay, C. Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(11): 942-953. Artículo. |
2,077 |
Q3 |
|
de Castro, J.; Gascón, P.; Casas, A.; Muñoz-Langa, J.; Alberola, V.; Cucala, M.; Barón, F. Iron deficiency in patients with solid tumours: prevalence and management in clinical practice. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(9): 823-828. Artículo. |
2,077 |
Q3 |
|
Remón, J.; Molina-Montes, E.; Majem, M.; Lianes, P.; Isla, D.; Garrido, P.; Felip, E.; Vinolas, N.; de Castro, J.; Artal, A.; Sánchez, M. J. Lung cancer in women: an overview with special focus on Spanish women. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(6): 517-528. Artículo. |
2,077 |
Q3 |
|
Martín-Algarra, S.; Fernández-Figueras, M. T.; López-Martín, J. A.; Santos-Briz, A.; Arance, A.; Lozano, M. D.; Berrocal, A.; Ríos-Martín, J. J.; Espinosa, E.; Rodríguez-Peralto, J. L. Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(4): 362-373. Artículo. |
2,077 |
Q3 |
|
García-Carbonero, R.; Vilardell, F.; Jiménez-Fonseca, P.; González- Campora, R.; González, E.; Cuatrecasas, M.; Capdevila, J.; Aranda, I.; Barriuso, J.; Matías-Guiu, X. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. CLINICAL & TRANSLATIONAL ONCOLOGY. 2014; 16(3): 243-256. Artículo. |
2,077 |
Q3 |
|
Pernía, O.; Belda-Iniesta, C.; Pulido, V.; Cortés-Sempere, M.; Rodríguez, C.; Vera, O.; Soto, J.; Jiménez, J.; Taus, A.; Rojo, F.; Arriola, E.; Rovira, A; Albanell, J.; Macías, M. T.; de Castro, J.; Perona, R.; Ibáñez de Caceres, I. Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy. EPIGENETICS. 2014; 9(11): 1446-1453. Artículo. |
4,78 |
Q1 |
|
Andre, S.; Singh, T.; Lacal, J. C.; Smetana, K.; Gabius, H. J. Rho GTPase rac 1: molecular switch within the galectin network and for N-glycan alpha 2,6-Sialylation/O-Glycan core 1 Sialylation in colon cancer in vitro. FOLIA BIOLOGICA. 2014; 60(3): 95-107. Artículo. |
1 |
Q3 |
|
Hur, K.; Cejas, P.; Feliú, J.; Moreno-Rubio, J.; Burgos, E.; Boland, C. R.; Goel, A. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. GUT. 2014; 63(4): 635-646. Artículo. |
14,66 |
D1 |
|
Milne, R. L.; Herranz, J.; Michailidou, K.; Dennis, J.; Tyrer, J. P.; Zamora, M. P.; Arias-Pérez, J. I.; González-Neira, A.; Pita, G.; Alonso, M. R.; Wang, Q.; Bolla, M. K.; Czene, K.; Eriksson, M.; Humphreys, K.; Darabi, H.; Li, J. M.; Antón-Culver, H.; Neuhausen, S. L.; Ziogas, A.; Clarke, C. A.; Hopper, J. L.; Dite, G. S.; Apicella, C.; Southey, M. C.; Chenevix-Trench, G.; Swerdlow, A.; Ashworth, A.; Orr, N.; Schoemaker, M.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Andrulism, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Nevanlinna, H. L.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Chang-Claude, J.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Wang, X. S.; Olson, J. E.; Vachon, C.; Purrington, K.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Dunning, A. M.; Shah, M.; Guenel, P.; Truong, T.; Sánchez, M.; Mulot, C.; Brenner, H.; Dieffenbach, A. K.; Arndt, V.; Stegmaier, C.; Lindblom, A.; Margolin, S.; Hooning, M. J.; Hollestelle, A.; Collee, J. M.; Jager, A.; Cox, A.; Brock, I. W.; Reed, M. W. R.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Simard, J.; Dumont, M.; Soucy, P.; Dork, T.; Bogdanova, N. V.; Hamann, U.; Forsti, A.; Rudiger, T.; Ulmer, H. U.; Fasching, P. A.; Haberle, L.; Ekici, A. B.; Beckmann, M. W.; Fletcher, O.; Johnson, N.; Silva, I. D. S.; Peto, J.; Radice, P.; Peterlongo, P.; Peissel, B.; Mariani, P.; Giles, G. G.; Severi, G.; Baglietto, L.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Marme, F.; Burwinkei, B.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Lambrechts, D.; Yesilyurt, B. T.; Floris, G.; Leunen, K.; Alnaes, G. G.; Kristensen, V.; Borresen-Dale, A. L.; García-Closas, M.; Chanock, S. J.; Lissowska, J.; Figueroa, J. D.; Schmidt, M. K.; Broeks, A.; Verhoef, S.; Rutgers, E. J.; Brauch, H.; Bruning, T.; Ko, Y. D.; Couch, F. J.; Toland, A. E.; Yannoukakos, D.; Pharoah, P. D. P.; Hall, P.; Benítez, J.; Malats, N.; Easton, D. F. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium. HUMAN MOLECULAR GENETICS. 2014; 23(7): 1934-1946. Artículo. |
6,393 |
Q1 |
|
Milne, R. L.; Burwinkel, B.; Michailidou, K.; Arias-Pérez, J. I.; Zamora, M. P.; Menéndez-Rodríguez, P.; Hardisson, D.; Mendiola, M.; González-Neira, A.; Pita, G.; Alonso, M. R.; Dennis, J.; Wang, Q.; Bolla, M. K.; Swerdlow, A.; Ashworth, A.; Orr, N.; Schoemaker, M.; Ko, Y. D.; Brauch, H.; Hamann, U.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Tchatchou, S.; Matsuo, K.; Ito, H.; Iwata, H.; Tajima, K.; Li, J. M.; Brand, J. S.; Brenner, H.; Dieffenbach, A. K.; Arndt, V.; Stegmaier, C.; Lambrechts, D.; Peuteman, G.; Christiaens, M. R.; Smeets, A.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Hartman, M.; Hui, M.; Lim, W. Y.; Chan, C. W.; Marme, F.; Yang, R. X.; Bugert, P.; Lindblom, A.; Margolin, S.; García-Closas, M.; Chanock, S. J.; Lissowska, J.; Figueroa, J. D.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Hooning, M. J.; Kriege, M.; van den Ouweland, A. M. W.; Koppert, L. B.; Fletcher, O.; Johnson, N.; Dos-Santos-Silva, I.; Peto, J.; Zheng, W.; Deming-Halverson, S.; Shrubsole, M. J.; Long, J. R.; Chang-Claude, J.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Cox, A.; Cross, S. S.; Reed, M. W. R.; Schmidt, M. K.; Broeks, A.; Cornelissen, S.; Braaf, L.; Kang, D.; Choi, J. Y.; Park, S. K.; Noh, D. Y.; Simard, J.; Dumont, M.; Goldberg, M. S.; Labreche, F.; Fasching, P. A.; Hein, A.; Ekici, A. B.; Beckmann, M. W.; Radice, P.; Peterlongo, P.; Azzollini, J.; Barile, M.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Hopper, J. L.; Schmidt, D. F.; Makalic, E.; Southey, M. C.; Teo, S. H.; Yip, C. H.; Sivanandan, K.; Tay, W. T.; Shen, C. Y.; Hsiung, C. N.; Yu, J. C.; Hou, M. F.; Guenel, P.; Truong, T.; Sanchez, M.; Mulot, C.; Blot, W.; Cai, Q. Y.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Wu, A. H.; Tseng, C. C.; Van den Berg, D.; Stram, D. O.; Bogdanova, N.; Dork, T.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Shu, X. O.; Lu, W.; Gao, Y. T.; Zhang, B.; Couch, F. J.; Toland, A. E.; Yannoukakos, D.; Sangrajrang, S.; McKay, J.; Wang, X. S.; Olson, J. E.; Vachon, C.; Purrington, K.; Severi, G.; Baglietto, L.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; Czene, K.; Eriksson, M.; Humphreys, K.; Darabi, H.; Ahmed, S.; Shah, M.; Pharoah, P. D. P.; Hall, P.; Giles, G. G.; Benítez, J.; Dunning, A. M.; Chenevix-Trench, G.; Easton, DF. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. HUMAN MOLECULAR GENETICS. 2014; 23(22): 6096-6111. Artículo. |
6,393 |
Q1 |
|
Purrington, K. S.; Slettedahl, S.; Bolla, M. K.; Michailidou, K.; Czene, K.; Nevanlinna, H.; Bojesen, S. E.; Andrulis, I. L.; Cox, A.; Hall, P.; Carpenter, J.; Yannoukakos, D.; Haiman, C. A.; Fasching, P. A.; Mannermaa, A.; Winqvist, R.; Brenner, H.; Lindblom, A.; Chenevix-Trench, G.; Benítez, J.; Swerdlow, A.; Kristensen, V.; Guenel, P.; Meindl, A.; Darabi, H.; Eriksson, M.; Fagerholm, R.; Aittomaki, K.; Blomqvist, C.; Nordestgaard, B. G.; Nielsen, S. F.; Flyger, H.; Wang, X. S.; Olswold, C.; Olson, J. E.; Mulligan, A. M.; Knight, J. A.; Tchatchou, S.; Reed, M. W. R.; Cross, S. S.; Liu, J. J.; Li, J. M.; Humphreys, K.; Clarke, C.; Scott, R.; Fostira, F.; Fountzilas, G.; Konstantopoulou, I.; Henderson, B. E.; Schumacher, F.; le Marchand, L.; Ekici, A. B.; Hartmann, A.; Beckmann, M. W.; Hartikainen, J. M.; Kosma, V. M.; Kataja, V.; Jukkola-Vuorinen, A.; Pylkas, K.; Kauppila, S.; Dieffenbach, A. K.; Stegmaier, C.; Arndt, V.; Margolin, S.; Balleine, R.; Pérez, J. I. A.; Zamora, M. P.; Menéndez, P.; Ashworth, A.; Jones, M.; Orr, N.; Arveux, P.; Kerbrat, P.; Truong, T.; Bugert, P.; Toland, A. E.; Ambrosone, C. B.; Labreche, F.; Goldberg, M. S.; Dumont, M.; Ziogas, A.; Lee, E.; Dite, G. S.; Apicella, C.; Southey, M. C.; Long, J. R.; Shrubsole, M.; Deming-Halverson, S.; Ficarazzi, F.; Barile, M.; Peterlongo, P.; Durda, K.; Jaworska-Bieniek, K.; Tollenaar, R. A. E. M.; Seynaeve, C.; Bruning, T.; Ko, Y. D.; Van Deurzen, C. H. M.; Martens, J. W. M.; Kriege, M.; Figueroa, J. D.; Chanock, S. J.; Lissowska, J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Schneeweiss, A.; Tapper, W. J.; Gerty, S. M.; Durcan, L.; Mclean, C.; Milne, R. L.; Baglietto, L.; Silva, I. D.; Fletcher, O.; Johnson, N.; Van’T Veer, L. J.; Cornelissen, S.; Forsti, A.; Torres, D.; Rudiger, T.; Rudolph, A.; Flesch-Janys, D.; Nickels, S.; Weltens, C.; Floris, G.; Moisse, M.; Dennis, J.; Wang, Q.; Dunning, A. M.; Shah, M.; Brown, J.; Simard, J.; Anton-Culver, H.; Neuhausen, S. L.; Hopper, J. L.; Bogdanova, N.; Dork, T.; Zheng, W.; Radice, P.; Jakubowska, A.; Lubinski, J.; Devillee, P.; Brauch, H.; Hooning, M.; García-Closas, M.; Sawyer, E.; Burwinkel, B.; Marmee, F.; Eccles, D. M.; Giles, G. G.; Peto, J.; Schmidt, M.; Broeks, A.; Hamann, U.; Chang-Claude, J.; Lambrechts, D.; Pharoah, P. D. P.; Easton, D.; Pankratz, V. S.; Slager, S.; Vachon, C. M.; Couch, F. J. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. HUMAN MOLECULAR GENETICS. 2014; 23(22): 6034-6046. Artículo. |
6,393 |
Q1 |
|
Riesco-Eizaguirre, G.; Leoni, S. G.; Mendiola, M.; Estévez-Cebrero, M. A.; Gallego, M. I.; Redondo, A.; Hardisson, D.; Santisteban, P.; de la Vieja, A. NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2014; 99(7): E1199-E1208. Artículo. |
6,209 |
Q1 |
|
Monk, B. J.; Poveda, A.; Vergote, I.; Raspagliesi, F.; Fujiwara, K.; Bae, D. S.; Oaknin, A.; Ray-Coquard, I.; Provencher, D. M.; Karlan, B. Y.; Lhomme, C.; Richardson, G.; Rincon, D. G.; Coleman, R. L.; Herzog, T. J.; Marth, C.; Brize, A.; Fabbro, M.; Redondo, A.; Bamias, A.; Tassoudji, M.; Navale, L.; Warner, D. J.; Oza, A. M. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. LANCET ONCOLOGY. 2014; 15(8): 799-808. Artículo. |
24,69 |
D1 |
|
Larkin, J.; del Vecchio, M.; Ascierto, P. A.; Krajsova, I.; Schachter, J.; Neyns, B.; Espinosa, E.; Garbe, C.; Sileni, V. C.; Gogas, H.; Miller, W. H.; Mandala, M.; Hospers, G. A. P.; Arance, A.; Queirolo, P.; Hauschild, A.; Brown, M. P.; Mitchell, L.; Veronese, L.; Blank, C. U. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study. LANCET ONCOLOGY. 2014; 15(4): 436-444. Artículo. |
24,69 |
D1 |
|
Butts, C.; Socinski, M. A.; Mitchell, P. L.; Thatcher, N.; Havel, L.; Krzakowski, M.; Nawrocki, S.; Ciuleanu, T. E.; Bosquee, L.; Trigo, J. M.; Spira, A.; Tremblay, L.; Nyman, J.; Ramlau, R.; Wickart-Johansson, G.; Ellis, P.; Gladkov, O.; Pereira, J. R.; Eberhardt, W. E. E.; Helwig, C.; Schroder, A.; Shepherd, F. A. (de Castro, J.). Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. LANCET ONCOLOGY. 2014; 15(1): 59-68. Artículo. |
24,69 |
D1 |
|
Reguart, N.; Rosell, R.; Cardenal, F.; Cardona, A. F.; Isla, D.; Palmero, R.; Morán, T.; Rolfo, C.; Pallares, M. C.; Insa, A.; Carcereny, E.; Majem, M.; de Castro, J.; Queralt, C.; Molina, M. A.; Taron, M. Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression. LUNG CANCER. 2014; 84(2): 161-167. Artículo. |
3,958 |
Q1 |
|
Berrocal, A.; Arance, A.; Martín, J. A. L.; Soriano, V.; Muñoz, E.; Alonso, L.; Espinosa, E.; Criado, P. L.; Valdivia, J.; Algarra, S. M. Ipilimumab for advanced melanoma: experience from the Spanish expanded access program. MELANOMA RESEARCH. 2014; 24(6): 577-583. Article. |
2,282 |
Q2 |
|
Custodio, A.; Moreno-Rubio, J.; Aparicio, J.; Gallego-Plazas, J.; Yaya, R.; Maurel, J.; Rodríguez-Salas, N.; Burgos, E.; Ramos, D.; Calatrava, A.; Andrada, E.; Díaz-López, E.; Sánchez, A.; Madero, R.; Cejas, P.; Feliú, J. Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy. MOLECULAR CANCER THERAPEUTICS. 2014; 13(9): 2226-2237. Artículo. |
5,683 |
Q1 |
|
Vargas, T.; Moreno-Rubio, J.; Herranz, J.; Cejas, P.; Molina, S.; González-Vallinas, M.; Ramos, R.; Burgos, E.; Aguayo, C.; Custodio, A. B.; Reglero, G.; Feliú, J.; de Molina, A. R. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer. MOLECULAR ONCOLOGY. 2014; 8(8): 1469-1481. Artículo. |
5,331 |
Q1 |
|
Ghoussaini, M.; Edwards, S. L.; Michailidou, K.; Nord, S.; Lari, R. C. S.; Desai, K.; Kar, S.; Hillman, K. M.; Kaufmann, S.; Glubb, D. M.; Beesley, J.; Dennis, J.; Bolla, M. K.; Wang, Q.; Dicks, E.; Guo, Q.; Schmidt, M. K.; Shah, M.; Luben, R.; Brown, J.; Czene, K.; Darabi, H.; Eriksson, M.; Klevebring, D.; Bojesen, S. E.; Nordestgaard, B. G.; Nielsen, S. F.; Flyger, H.; Lambrechts, D.; Thienpont, B.; Neven, P.; Wildiers, H.; Broeks, A.; Van’t Veer, L. J.; Rutgers, E. J. T.; Couch, F. J.; Olson, J. E.; Hallberg, E.; Vachon, C.; Chang-Claude, J.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Peto, J.; dos-Santos-Silva, I.; Gibson, L.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Hall, P.; Li, J. M.; Liu, J. J.; Humphreys, K.; Kang, D.; Choi, J. Y.; Park, S. K.; Noh, D. Y.; Matsuo, K.; Ito, H.; Iwata, H.; Yatabe, Y.; Guenel, P.; Truong, T.; Menegaux, F.; Sánchez, M.; Burwinkel, B.; Marme, F.; Schneeweiss, A.; Sohn, C.; Wu, A. H.; Tseng, C. C.; van den Berg, D.; Stram, D. O.; Benitez, J.; Zamora, M. P.; Pérez, J. I. A.; Menéndez, P.; Shu, X. O.; Lu, W.; Gao, Y. T.; Cai, Q. Y.; Cox, A.; Cross, S. S.; Reed, M. W. R.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Tchatchou, S.; Sawyer, E. J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; le Marchand, L.; Lindblom, A.; Margolin, S.; Teo, S. H.; Yip, C. H.; Lee, D. S. C.; Wong, T. Y.; Hooning, M. J.; Martens, J. W. M.; Collee, J. M.; van Deurzen, C. H. M.; Hopper, J. L.; Southey, M. C.; Tsimiklis, H.; Kapuscinski, M. K.; Shen, C. Y.; Wu, P. E.; Yu, J. C.; Chen, S. T.; Alnaes, G. G.; Borresen-Dale, A. L.; Giles, G. G.; Milne, R. L.; McLean, C.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Hartman, M.; Miao, H.; Buhari, S. A. B.; Teo, Y. Y.; Fasching, P. A.; Haeberle, L.; Ekici, A. B.; Beckmann, M. W.; Brenner, H.; Dieffenbach, A. K.; Arndt, V.; Stegmaier, C.; Swerdlow, A.; Ashworth, A.; Orr, N.; Schoemaker, M. J.; García-Closas, M.; Figueroa, J.; Chanock, S. J.; Lissowska, J.; Simard, J.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Brauch, H.; Bruning, T.; Koto, Y. D.; Radice, P.; Peterlongo, P.; Bonanni, B.; Volorio, S.; Dork, T.; Bogdanova, N. V.; Helbig, S.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; Van Asperen, C. J.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Slager, S.; Toland, A. E.; Ambrosone, C. B.; Yannoukakos, D.; Sangrajrang, S.; Gaborieau, V.; Brennan, P.; Mckay, J.; Hamann, U.; Torres, D.; Zheng, W.; Long, J. R.; Anton-Culver, H.; Neuhausen, S. L.; Luccarini, C.; Baynes, C.; Ahmed, S.; Maranian, M.; Healey, C. S.; González-Neira, A.; Pita, G.; Alonso, M. R.; Álvarez, N.; Herrero, D.; Tessier, D. C.; Vincent, D.; Bacot, F.; de Santiago, I.; Carroll, J.; Caldas, C.; Brown, M. A.; Lupien, M.; Kristensen, V. N.; Pharoah, P. D. P.; Chenevix-Trench, G.; French, J. D.; Easton, D. F.; Dunning, A. M. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. NATURE COMMUNICATIONS. 2014; 5: 4999. Artículo. |
11,47 |
D1 |
|
Redondo, A.; Martínez, V.; Zamora, P.; Castelo, B.; Pinto, A.; Cruz, P.; Higuera, O.; Mendiola, M.; Hardisson, D.; Espinosa, E. Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer. ONCOTARGETS AND THERAPY. 2014; 7: 2175-2181. Artículo. |
2,311 |
Q2 |
|
Khan, S.; Greco, D.; Michailidou, K.; Milne, R. L.; Muranen, T. A.; Heikkinen, T.; Aaltonen, K.; Dennis, J.; Bolla, M. K.; Liu, J.; Hall, P.; Irwanto, A.; Humphreys, K.; Li, J.; Czene, K.; Chang-Claude, J.; Hein, R.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Fletcher, O.; Peto, J.; Silva, I. D.; Johnson, N.; Gibson, L.; Aitken, Z.; Hopper, J. L.; Tsimiklis, H.; Bui, M.; Makalic, E.; Schmidt, D. F.; Southey, M. C.; Apicella, C.; Stone, J.; Waisfisz, Q.; Meijers-Heijboer, H.; Adank, M. A.; van der Luijt, R. B.; Meindl, A.; Schmutzler, R. K.; Muller-Myhsok, B.; Lichtner, P.; Turnbull, C.; Rahman, N.; Chanock, S. J.; Hunter, D. J.; Cox, A.; Cross, S. S.; Reed, M. W. R.; Schmidt, M. K.; Broeks, A.; Van’t Veer, L. J.; Hogervorst, F. B.; Fasching, P. A.; Schrauder, M. G.; Ekici, A. B.; Beckmann, M. W.; Bojesen, S. E.; Nordestgaard, B. G.; Nielsen, S. F.; Flyger, H.; Benítez, J.; Zamora, P. M.; Pérez, J. I. A.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Pharoah, P. D. P.; Dunning, A. M.; Shah, M.; Luben, R.; Brown, J.; Couch, F. J.; Wang, X.; Vachon, C.; Olson, J. E.; Lambrechts, D.; Moisse, M.; Paridaens, R.; Christiaens, M. R.; Guenel, P.; Truong, T.; Laurent-Puig, P.; Mulot, C.; Marme, F.; Burwinkel, B.; Schneeweiss, A.; Sohn, C.; Sawyer, E. J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Andrulis, I. L.; Knight, J. A.; Tchatchou, S.; Mulligan, A. M.; Dork, T.; Bogdanova, N. V.; Antonenkova, N. N.; Antón-Culver, H.; Darabi, H.; Eriksson, M.; García-Closas, M.; Figueroa, J.; Lissowska, J.; Brinton, L.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; van Asperen, C. J.; Kristensen, V. N.; Slager, S.; Toland, A. E.; Ambrosone, C. B.; Yannoukakos, D.; Lindblom, A.; Margolin, S.; Radice, P.; Peterlongo, P.; Barile, M.; Mariani, P.; Hooning, M. J.; Martens, J. W. M.; Collee, J. M.; Jager, A.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Giles, G. G.; McLean, C.; Brauch, H.; Bruning, T.; Ko, Y. D.; Brenner, H.; Dieffenbach, A. K.; Arndt, V.; Stegmaier, C.; Swerdlow, A.; Ashworth, A.; Orr, N.; Jones, M.; Simard, J.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Mannermaa, A.; Hamann, U.; Chenevix-Trench, G.; Blomqvist, C.; Aittomaki, K.; Easton, D. F.; Nevanlinna, H. MicroRNA related polymorphisms and breast cancer risk. PLOS ONE. 2014; 9(11): e10973. Artículo. |
3,234 |
Q1 |
|
Gámez-Pozo, A.; Pérez Carrión, R. M.; Mansó, L.; Crespo, C.; Mendiola, C.; López-Vacas, R.; Berges-Soria, J.; López, I. A.; Margeli, M.; Calero, J. L. B.; Farre, X. G.; Santaballa, A.; Ciruelos, E. M.; Afonso, R.; Lao, J.; Catalán, G.; Gallego, J. V. A.; López, J. M.; Bofill, F. J. S.; Borrego, M. R.; Espinosa, E.; Vara, J. A. F.; Zamora, P. The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. PLOS ONE. 2014; 9(10): e109611. Artículo. |
3,234 |
Q1 |
|
Conde, E.; Suárez-Gauthier, A.; Benito, A.; Garrido, P.; García-Campelo, R.; Biscuola, M.; Paz-Ares, L.; Hardisson, D.; de Castro, J.; Camacho, M. C.; Rodríguez-Abreu, D.; Abdulkader, I.; Ramírez, J.; Reguart, N.; Salido, M.; Pijuan, L.; Arriola, E.; Sanz, J.; Folgueras, V.; Villanueva, N.; Gómez-Román, J.; Hidalgo, M.; López-Ríos, F. Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry. PLOS ONE. 2014; 9(9): e107200. Artículo. |
3,234 |
Q1 |
|
Aparicio, J.; García-Mora, C.; Martín, M.; Petriz, M. L.; Feliú, J.; Sánchez-Santos, M. E.; Ayuso, J. R.; Fuster, D.; Conill, C.; Maurel, J. A Phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) Study. PLOS ONE. 2014; 9(1): e82209. Artículo. |
3,234 |
Q1 |
|
Cruzado, J. A.; López-Santiago, S.; Martínez-Marín, V.; José-Moreno, G.; Custodio, A. B.; Feliú, J. Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. SUPPORTIVE CARE IN CANCER. 2014; 22(7): 1815-1823. Artículo. |
2,364 |
Q1 |
|
Lamarca, A.; Feliú, J. Pancreatic biomarkers: could they be the answer? WORLD JOURNAL OF GASTROENTEROLOGY. 2014; 20(24): 7819-7829. Artículo. |
2,369 |
Q3 |
|
Monk, B. J.; Poveda, A.; Vergote, I.; Raspagliesi, F.; Fujiwara, K.; Bae, D. S.; Oaknin, A.; Ray-Coquard, I.; Provencher, D. M.; Karlan, B. Y.; Lhomme, C.; Richardson, G.; Rincon, D. G.; Coleman, R. L.; Herzog, T. J.; Marth, C.; Brize, A.; Fabbro, M.; Redondo, A.; Bamias, A.; Tassoudji, M.; Navale, L.; Warner, D. J.; Oza, A. M. Anti-Angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. OBSTETRICAL & GYNECOLOGICAL SURVEY. 2014; 69(11): 661-662. Material Editorial. |
1,863 |
Q2 |
|
Fernández-Martos, C.; Brown, G.; Estevan, R.; Salud, A.; Montagut, C.; Maurel, J.; Safont, M. J.; Aparicio, J.; Feliú, J.; Vera, R.; Alonso, V.; Gallego, J.; Martín, M.; Pera, M.; Sierra, E.; Serra, J.; Delgado, S.; Roig, J. V.; Santos, J.; Pericay, C. Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 phase II multicenter trial. ONCOLOGIST. 2014; 19(10): 1042-1043. Material. Editorial. |
4,865 |
Q1 |
|
Cruz, P.; Torres, M.; Higuera, O.; Espinosa, E. Taxane-induced pneumonitis: our clinical experience. ARCHIVOS DE BRONCONEUMOLOGÍA. 2014; 50(1): 45. Carta. |
1,823 |
Q3 |
|
Moreno, V.; García-Carbonero, R.; Maurel, J.; Feliú, J. Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, And radiotherapy in patients with locally advanced anal canal carcinoma. CANCER. 2014; 120(3): 454-456. Carta. |
4,889 |
Q1 |
|
Berrocal, A.; Cabañas, L.; Espinosa, E.; Fernández-de-Misa, R.; Martín-Algarra, S.; Martínez-Cedres, J. C.; Ríos-Buceta, L.; Rodríguez-Peralto, J. L. Melanoma: diagnosis, staging, And treatment. Consensus group recommendations. ADVANCES IN THERAPY. 2014; 31(9): 945-960. Revisión. |
2,272 |
Q3 |
|
Ghanem, I.; Riveiro, M. E.; Paradis, V.; Faivre, S.; Vázquez de Parga, P. M.; Raymondm, E. Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. 2014; 6(4): 340–352. Revisión. |
3,402 |
Q2 |
|
García-Alfonso, P.; Grande, E.; Polo, E.; Afonso, R.; Reina, J. J.; Jorge, M.; Campos, J. M.; Martínez, V.; Angeles, C.; Montagut, C. The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status. ANGIOGENESIS. 2014; 17(4): 805-821. Revisión. |
4,876 |
Q1 |
|
Pinto, A. Beyond abiraterone new hormonal therapies for metastatic castration-resistant prostate cancer. CANCER BIOLOGY & THERAPY. 2014; 15(2): 149-155. Revisión. |
3,072 |
Q2 |
|
Pinto, A. Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2014; 73(2): 219-222. Revisión. |
2,769 |
Q2 |
|
Poveda, A.; del Muro, X. G.; López-Guerrero, J. A.; Martínez, V.; Romero, I.; Valverde, C.; Cubedo, R.; Martín-Broto, J. GEIS 2013 guidelines for gastrointestinal sarcomas (GIST). CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2014; 74(5): 883-898. Revisión. |
2,769 |
Q2 |
|
Pinto, A. Adjuvant therapy for renal cell carcinoma. CLINICAL GENITOURINARY CANCER. 2014; 12: 408-12. Revisión. |
2,322 |
Q2 |
Publicaciones 2009 - 2013
|
AÑO |
DENOMINACIÓN |
F.I. |
CUARTIL |
|
2013 |
Meyer, K. B.; O’Reilly, M.; Michailidou, K.; Carlebur, S.; Edwards, S. L.; French, J. D.; Prathalingham, R.; Dennis, J.; Bolla, M. K.; Wang, Q.; de Santiago, I.; Hopper, J. L.; Tsimiklis, H.; Apicella, C.; Southey, M. C.; Schmidt, M. K.; Broeks, A.; van’t Veer, L. J.; Hogervorst, F. B.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Fasching, P. A.; Lux, M. P.; Ekici, A. B.; Beckmann, M. W.; Peto, J.; Silva, I. D.; Fletcher, O.; Johnson, N.; Sawyer, E. J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Marme, F.; Schneeweiss, A.; Sohn, C.; Burwinkel, B.; Guenel, P.; Truong, T.; Laurent-Puig, P.; Menegaux, F.; Bojesen, S. E.; Nordestgaard, B. G.; Nielsen, S. F.; Flyger, H.; Milne, R. L.; Zamora, M. P.; Arias, J. I.; Benítez, J.; Neuhausen, S.; Antón-Culver, H.; Ziogas, A.; Dur, C. C.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Meindl, A.; Schmutzler, R. K.; Engel, C.; Ditsch, N.; Brauch, H.; Bruning, T.; Ko, Y. D.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Matsuo, K.; Ito, H.; Iwata, H.; Yatabe, Y.; Dork, T.; Helbig, S.; Bogdanova, N. V.; Lindblom, A.; Margolin, S.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Chenevix-Trench, G.; Wu, A. H.; Tseng, C. C.; Van Den Berg, D.; Stram, D. O.; Lambrechts, D.; Thienpont, B.; Christiaens, M. R.; Smeets, A.; Chang-Claude, J.; Rudolph, A.; Seibold, P.; Flesch-Janys, D.; Radice, P.; Peterlongo, P.; Bonanni, B.; Bernard, L.; Couch, F. J.; Olson, J. E.; Wang, X. S.; Purrington, K.; Giles, G. G.; Severi, G.; Baglietto, L.; McLean, C.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Simard, J.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Teo, S. H.; Yip, C. H.; Phuah, S. Y.; Kristensen, V.; Alnaes, G. G.; Borresen-Dale, A. L.; Zheng, W.; Deming-Halverson, S.; Shrubsole, M.; Long, J. R.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Kauppila,
S.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Tchatchou, S.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C. M.; García-Closas, M.; Figueroa, J.; Chanock, S. J.; Lissowska, J.; Czene, K.; Darabi, H.; Eriksson, K.; Hooning, M. J.; Martens, J. W. M.; van den Ouweland, A. M. W.; van Deurzen, C. H. M.; Hall, P.; Li, J. M.; Liu, J. J.; Humphreys, K.; Shu, X. O.; Lu, W.; Gao, Y. T.; Cai, H.; Cox, A.; Reed, M. W. R.; Blot, W.; Signorello, L. B.; Cai, Q. Y.; Pharoah, P. D. P.; Ghoussaini, M.; Harrington, P.; Tyrer, J.; Kang, D.; Choi, J. Y.; Park, S. K.; Noh, D. Y.; Hartman, M.; Hui, M.; Lim, W. Y.; Buhari, S. A.; Hamann, U.; Forsti, A.; Rudiger, T.; Ulmer, H. U.; Jakubowska, A.; Lubinski, J.; Jaworska, K.; Durda, K.; Sangrajrang, S.; Gaborieau, V.; Brennan, P.; Mckay, J.; Vachon, C.; Slager, S.; Fostira, F.; Pilarski, R.; Shen, C. Y.; Hsiung, C. N.; Wu, P. E.; Hou, M. F.; Swerdlow, A.; Ashworth, A.; Orr, N.; Schoemaker, M. J.; Ponder, B. A. J.; Dunning, A. M.; Easton, D. F. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. AMERICAN JOURNAL OF HUMAN GENETICS. 2013; 93(6): 1046-1060. Artículo. |
10,987 |
D1 |
|
2013 |
French, J. D.; Ghoussaini, M.; Edwards, S. L.; Meyer, K. B.; Michailidou, K.; Ahmed, S.; Khan, S.; Maranian, M. J.; O’Reilly, M.; Hillman, K. M.; Betts, J. A.; Carro, T.; Bailey, P. J.; Dicks, E.; Beesley, J.; Tyrer, J.; Maia, A. T.; Beck, A.; Knoblauch, N. W.; Chen, C.; Kraft, P.; Barnes, D.; González-Neira, A.; Alonso, M. R.; Herrero, D.; Tessier, D. C.; Vincent, D.; Bacot, F.; Luccarini, C.; Baynes, C.; Conroy, D.; Dennis, J.; Bolla, M. K.; Wang, Q.; Hopper, J. L.; Southey, M. C.; Schmidt, M. K.; Broeks, A.; Verhoef, S.; Cornelissen, S.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Fasching, P. A.; Loehberg, C. R.; Ekici, A. B.; Beckmann, M. W.; Peto, J.; Silva, I. D. S.; Johnson, N.; Aitken, Z.; Sawyer, E. J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Marme, F.; Schneeweiss, A.; Sohn, C.; Burwinkel, B.; Guenel, P.; Truong, T.; Laurent-Puig, P.; Menegaux, F.; Bojesen, S. E.; Nordestgaard, N. G.; Nielsen, S. F.; Flyger, H.; Milne, R. L.; Zamora, M. P.; Pérez, J. I. A.; Benítez, J.; Antón-Culver, H.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Meind, A.; Lichtner, P.; Schmutzler, R. K.; Engel, C.; Brauch, H.; Hamann, U.; Justenhoven, C.; Aaltonen, K.; Heikkila, P.; Aittomaki, K.; Blomqvist, C.; Matsuo, K.; Ito, H.; Iwata, H.; Sueta, A.; Bogdanova, N. V.; Antonenkova, N. N.; Dork, T.; Lindblom, A.; Margolin, S.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Wu, A. H.; Tseng, C. C.; van Den Berg, D.; Stram, D. O.; Lambrechts, D.; Peeters, S.; Smeets, A.; Floris, G.; Chang-Claude, J.; Rudolph, A.; Nickels, S.; Flesch-Janys, D.; Radice, P.; Peterlongo, P.; Bonanni, B.; Sardella, D.; Couch, F. J.; Wang, X. S.; Pankratz, V. S.; Lee, A.; Giles, G. G.; Severi, G.; Baglietto, L.; Haiman, C. A.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Simard, J.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Teo, S. H.; Yip, C. H.; Ng, C. H.; Vithana, E. N.; Kristensen, V.; Zheng, W.; Deming-Halverson, S.; Shrubsole, M.; Long, J. R.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Devilee, P.; Seynaeve, C.; García-Closas, M.; Figueroa, J.; Chanock, S. J.; Lissowska, J.; Czene, K.; Klevebring, D.; Schoof, N.; Hooning, M. J.; Martens, J. W. M.; Collee, J. M.; Tilanus-Linthorst, M.; Hall, P.; Li, J. M.; Liu, J. J.; Humphreys, K.; Shu, X. O.; Lu, W.; Gao, Y. T.; Cai, H.; Cox, A.; Balasubramanian, S. P.; Blot, W.; Signorello, L. B.; Cai, Q. Y.; Pharoah, P. D. P.; Healey, C. S.; Shah, M.; Pooley, K. A.; Kang D.; Yoo, K. Y.; Noh, D. Y.; Hartman, M.; Miao, H.; Sng, J. H.; Sim, X.; Jakubowska, A.; Lubinski, J.; Jaworska-Bieniek, K.; Durda, K.; Sangrajrang, S.; Gaborieau, V.; McKay, J.; Toland, A. E.; Ambrosone, C. B.; Yannoukakos, D.; Godwin, A. K.; Shen, C.Y.; Hsiung, C. N.; Wu, P. E.; Chen, S. T.; Swerdlow, A.; Ashworth, A.; Orr, N.; Schoemaker, M. J.; Ponder, B. A. J.; Nevanlinna, H.; Brown, M. A.; Chenevix-Trench, G.; Easton, D. F.; Dunning, A. M. Functional variants at the 11q13 risk locus for breast cancer regulate cCyclin D1 expression through long-range enhancers. AMERICAN JOURNAL OF HUMAN GENETICS. 2013; 92(4): 489-503. Artículo. |
10,987 |
D1 |
|
2013 |
Provencio, M.; Sánchez, A.; Artal, A.; Torres, J. M. S.; de Castro, J.; Domine, M.; Viñolas, N.; Sánchez, A.; Pérez, F. J. Cisplatin plus oral vinorelbine as first-line treatment for advanced nonsmall cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary. CLINICAL & TRANSLATIONAL ONCOLOGY. 2013; 15(8): 659-664. Artículo. |
1,6 |
Q4 |
|
2013 |
Martín, A. G.; Redondo, A.; Jurado, M.; de Juan, A.; Romero, I.; Bover, I.; del Campo, J. M.; Cervantes, A.; García, Y.; López-Guerrero, J. A.; Mendiola, C.; Palacios, J.; Rubio, M. J.; Velasco, A. P. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. CLINICAL & TRANSLATIONAL ONCOLOGY. 2013; 15(7): 509-525. Artículo. |
1,6 |
Q4 |
|
2013 |
Casado-Sáenz, E.; Feliu, J.; Gómez-España, M. A.; Sánchez-Gastaldo, A.; García-Carbonero, R. SEOM clinical guidelines for the treatment of advanced colorectal cancer 2013. CLINICAL & TRANSLATIONAL ONCOLOGY. 2013; 15(12): 996-1003. Artículo. |
1,6 |
Q4 |
|
2013 |
Redondo, A.; Cruz, J.; López-Pousa, A.; Barón, F. SEOM clinical
guidelines for the treatment of osteosarcoma in adults-2013. CLINICAL & TRANSLATIONAL ONCOLOGY. 2013; 15(12): 1037-1043. Artículo. |
1,6 |
Q4 |
|
2013 |
Reardon, D. A.; Groves, M. D.; Wen, P. Y.; Nabors, L.; Mikkelsen,
T.; Rosenfeld, S.; Raizer, J.; Barriuso, J.; McLendon, R. E.; Suttle, A. B.; Ma, B.; Curtis, C. M.; Dar, M. M.; de Bono, J. A Phase I/II trial of pazopanib in combination with lapatinib in adult patients with Relapsed Malignant Glioma. CLINICAL CANCER RESEARCH. 2013; 19(4): 900-908. Artículo. |
8,193 |
D1 |
|
2013 |
Casado-Vela, J.; González-González, M.; Matarraz, S.; Martínez-Esteso, M. J.; Vilella, M.; Sayagues, J. M.; Fuentes, M.; Lacal, J. C. Protein arrays: recent achievements and their application to study the human proteome. CURRENT PROTEOMICS. 2013; 10(2): 83-97. Artículo. |
0,44 |
Q4 |
|
2013 |
Martín-Richard, M.; Gallego, R.; Pericay, C.; Foncillas, J. G.; Queralt, B.; Casado, E.; Barriuso, J.; Iranzo, V.; Juez, I.; Visa, L.; Saigi, E.; Barnadas, A.; García-Albéniz, X.; Maurel, J. Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study. INVESTIGATIONAL NEW DRUGS. 2013; 31(6): 1573-1579. Artículo. |
2,927 |
Q2 |
|
2013 |
Azim, H. A.; Kroman, N.; Paesmans, M.; Gelber, S.; Rotmensz, N.; Ameye, L.; de Mattos-Arruda, L.; Pistilli, B.; Pinto, A.; Jensen, M. B.; Córdoba, O.; de Azambuja, E.; Goldhirsch, A.; Piccart, M. J.; Peccatori, F. A. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. JOURNAL OF CLINICAL ONCOLOGY. 2013; 31(1): 73-79. Artículo. |
17,879 |
D1 |
|
2013 |
Grothey, A.; van Cutsem, E.; Sobrero, A.; Siena, S.; Falcone, A.; Ychou, M.; Humblet, Y.; Bouche, O.; Mineur, L.; Barone, C.; Adenis, A.; Tabernero, J.; Yoshino, T.; Lenz, H. J.; Goldberg, R. M.; Sargent, D. J.; Cihon, F.; Cupit, L.; Wagner, A.; Laurent, D. (Feliu, J.). Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. LANCET. 2013; 381(9863): 303-312. Artículo. |
39,207 |
D1 |
|
2013 |
Michailidou, K.; Hall, P.; González-Neira, A.; Ghoussaini, M.; Dennis, J.; Milne, R. L.; Schmidt, M. K.; Chang-Claude, J.; Bojesen, S. E.; Bolla, M. K.; Wang, Q.; Dicks, E.; Lee, A.; Turnbull, C.; Rahman, N.; Fletcher, O.; Peto, J.; Gibson, L.; Silva, I. D.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Czene, K.; Irwanto, A.; Liu, J. J.; Waisfisz, Q.; Meijers-Heijboer, H.; Adank, M.; van der Luijt, R. B.; Hein, R.; Dahmen, N.; Beckman, L.; Meindl, A.; Schmutzler, R. K.; Muller-Myhsok, B.; Lichtner, P.; Hopper, J. L.; Southey, M. C.; Makalic, E.; Schmidt, D. F.; Uitterlinden, A. G.; Hofman, A.; Hunter, D. J.; Chanock, S. J.; Vincent, D.; Bacot, F.; Tessier, D. C.; Canisius, S.; Wessels, L.F. A.; Haiman, C. A.; Shah, M.; Luben, R.; Brown, J.; Luccarini, C.; Schoof, N.; Humphreys, K.; Li, J. M.; Nordestgaard, B. G.; Nielsen, S. F.; Flyger, H.; Couch, F. J.; Wang, X. S.; Vachon, C.; Stevens, K. N.; Lambrechts, D.; Moisse, M.; Paridaens, R.; Christiaens, M. R.; Rudolph, A.; Nickels, S.; Flesch-Janys, D.; Johnson, N.; Aitken, Z.; Aaltonen, K.; Heikkinen, T.; Broeks, A.; van’t Veer, L. J.; van der Schoot, C. E.; Guenel, P.; Truong, T.; Laurent-Puig, P.; Menegaux, F.; Marme, F.; Schneeweiss, A.; Sohn, C.; Burwinke, B.; Zamora, M. P.; Pérez, J. I. A.; Pita, G.; Alonso, M. R.; Cox, A.; Brock, I. W.; Cross, S. S.; Reed, M. W. R.; Sawyer, E. J.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Henderson, B. E.; Schumacher, F.; Le Marchand, L.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Lindblom, A.; Margolin, S.; Hooning, M. J.; Hollestelle, A.; van den Ouweland, A. M. W.; Jager, A.; Bui, Q. M.; Stone, J.; Dite, G. S.; Apicella, C.; Tsimiklis, H.; Giles, G. G.; Severi, G.; Baglietto, L.; Fasching, P. A.; Haeberle, L.; Ekici, A. B.; Beckmann, M. W.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Swerdlown, A.; Ashworth, A.; Orr, N.; Jones, M.; Figueroa, J.; Lissowska, J.; Brinton, L.; Goldberg, M. S.; Labreche, F.; Dumont, M.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Brauch, H.; Hamann, U.; Bruning, T.; Radice, P.; Peterlongo, P.; Manouldan, S.; Bonanni, B.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.; van Asperen, C. J.; Jakubowska, A.; Lubinski, J.; Jaworska, K.; Durda, K.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Bogdanova, N. V.; Antonenkova, N. N.; Dork, T.; Kristensen, V. N.; Anton-Culver, H.; Slager, S.; Toland, A. E.; Edge, S.; Fostira, F.; Kang, D.; Yoo, K. Y.; Noh, DY.; Matsuo, K.; Ito, H.; Iwata, H.; Sueta, A.; Wu, A. H.; Tseng, C. C.; Van den Berg, D.; Stram, D. O.; Shu, X. O.; Lu, W.; Gao, Y. T.; Cai, H.; Teo, S. H.; Yip, C. H.; Phuah, S. Y.; Cornes, B. K.; Hartman, M.; Miao, H.; Lim, W. Y.; Sng, J. H.; Muir, K.; Lophatananon, A.; Stewart-Brown, S.; Siriwanarangsan, P.; Shen, C. Y.; Hsiung, C. N.; Wu, P. E.; Ding, S. L.; Sangrajrang, S.; Gaborieau, V.; Brennan, P.; Mckay, J.; Blot, W. J.; Signorello, L. B.; Cai, Q. Y.; Zheng, W.; Deming-Halverson, S.; Shrubsole, M.; Long, J. R.; Simard, J.; García-Closas, M.; Pharoah, P. D. P.; Chenevix-Trench, G.; Dunning, A. M.; Benítez, J.; Easton, D. F. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. NATURE GENETICS. 2013; 45(4): 353-361. Artículo. |
29,648 |
D1 |
|
2013 |
Bojesen, S. E.; Pooley, K. A.; Johnatty, S. E.; Beesley, J.; Michailidou,
K.; Tyrer, J. P.; Edwards, S. L.; Pickett, H. A.; Shen, H. C.; Smart, C. E.; Hillman, K. M.; Mai, P. L.; Lawrenson, K.; Stutz, M.D.; Lu, Y.; Karevan, R.; Woods, N.; Johnstonw, R. L.; French, J. D.; Chen, X. Q.; Weischer, M.; Nielsen, S. F.; Maranian, M. J.; Ghoussaini, M.; Ahmed, S.; Baynes, C.; Bolla, M. K.; Wang, Q.; Dennis, J.; McGuffog, L.; Barrowdale, D.; Lee, A.; Healey, S.; Lush, M.; Tessier, D. C.; Vincent, D.; Bacot, F.; Vergote, I.; Lambrechts, S.; Despierre, E.; Risch, H. A.; González-Neira, A.; Rossing, M. A.; Pita, G.; Doherty, J. A.; Álvarez, N.; Larson, M. C.; Fridley, B. L.; Schoof, N.; Chang-Claude, J.; Cicek, M. S.; Peto, J.; Kalli, K. R.; Broeks, A.; Armasu, S. M.; Schmidt, M. K.; Braaf, L. M.; Winterhoff, B.; Nevanlinna, H.; Konecny, G. E.; Lambrechts, D.; Rogmann, L.; Guenel, P.; Teoman, A.; Milne, R. L.; García, J. J.; Cox, A.; Shridhar, V.; Burwinkel, B.; Marme, F.; Hein, R.; Sawyer, E. J.; Haiman, C. A.; Wang-Gohrke, S.; Andrulis, I. L.; Moysich, K. B.; Hopper, J. L.; Odunsi, K.; Lindblom, A.; Giles, G. G.; Brenner, H.; Simard, J.; Lurie, G.; Fasching, P. A.; Carney, M. E.; Radice, P.; Wilkens, L. R.; Swerdlow, A.; Goodman, M. T.; Brauch, H.; García-Closas, M.; Hillemanns, P.; Winqvist, R.; Durst, M.; Devilee, P.; Runnebaum, I.; Jakubowska, A.; Lubinski, J.; Mannermaa, A.; Butzow, R.; Bogdanova, N. V.; Dork, T.; Pelttari, L. M.; Zheng, W.; Leminen, A.; Anton-Culver, H.; Bunker, C. H.; Kristensen, V.; Ness, R. B.; Muir, K.; Edwards, R.; Meind, A.; Heitz, F.; Matsuo, K.; du Bois, A.; Wu, A. H.; Harter, P.; Teo, S. H.; Schwaab, I.; Shu, X. O.; Blot, W.; Hosono, S.; Kang, D.; Nakanishi, T.; Hartman, M.; Yatabe, Y.; Hamann, U.; Karlan, B. Y.; Sangrajrang, S.; Kjaer, S. K.; Gaborieau, V.; Jensen, A.; Eccles, D.; Hogdall, E.; Shen, C. Y.; Brown, J.; Woo, Y. L.; Shah, M.; Azmi, M. A. N.; Luben, R.; Omar, S. Z.; Czene, K.; Vierkant, R. A.; Nordestgaard, B. G.; Flyger, H.; Vachon, C.; Olson, J. E.; Wang, X. S.; Levine, D. A.; Rudolph, A.; Weber, R. P.; Flesch-Janys, D.; Iversen, E.; Nickels, S.; Schildkraut, J. M.; Silva, I. D.; Cramer, D. W.; Gibson, L.; Terry, K. L.; Fletcher, O.; Vitonis, A. F.; van der Schoot, C. E.; Poole, E. M.; Hogervorst, F. B. L.; Tworoger, S. S.; Liu, J. J.; Bandera, E. V.; Li, J. M.; Olson, S. H.; Humphreys, K.; Row, I.; Blomqvist, C.; Rodríguez-Rodríguez, L.; Aittomaki, K.; Salvesen, H. B.; Muranen, T. A.; Wik, E.; Brouwers, B.; Krakstad, C.; Wauters, E.; Halle, M. K.; Wildiers, H.; Kiemeney, L. A.; Mulot, C.; Aben, K. K.; Laurent-Puig, P.; Altena, A. M.; Truong, T.; Massuger, L. F. A. G.; Benitez, J.; Pejovic, T.; Pérez, J. I. A.; Hoatlin, M.; Zamora, M. P.; Cook, L. S.; Balasubramanian, S. P.; Kelemen, L. E.; Schneeweiss, A.; Le, N. D.; Sohn, C.; Brooks-Wilson, A.; Tomlinson, I.; Kerin, M. J.; Miller, N.; Cybulski, C.; Henderson, B. E.; Menkiszak, J.; Schumacher, F.; Wentzensen, N.; Le Marchand, L.; Yang, H. P.; Mulligan, A. M.; Glendon, G.; Engelholm, S. A.; Knight, J. A.; Hogdall, C. K.; Apicella, C.; Gore, M.; Tsimiklis, H.; Song, H. L.; Southey, M. C.; Jager, A.; den Ouweland, A. M. W.; Brown, R.; Martens, J. W. M.; Flanagan, J. M.; Kriege, M.; Paul, J.; Margolin, S.; Siddiqui, N.; Severi, G.; Whittemore, A. S.; Baglietto, L.; McGuire, V.; Stegmaier, C.; Sieh, W.; Muller, H.; Arndt, V.; Labreche, F.; Gao, Y. T.; Goldberg, M. S.; Yang, G.; Dumont, M.; McLaughlin, J. R.; Hartmann, A.; Ekici, A. B.; Beckmann, M. W.; Phelan, C. M.; Lux, M. P.; Permuth-Wey, J.; Peissel, B.; Sellers, T. A.; Ficarazzi, F.; Barile, M.; Ziogas, A.; Ashworth, A.; Gentry-Maharaj, A.; Jones, M.; Ramus, S. J.; Orr, N.; Menon, U.; Pearce, C. L.; Bruning, T.; Pike, M. C.; Ko, Y. D.; Lissowska, J.; Figueroa, J.; Kupryjanczyk, J.; Chanock, S. J.; Dansonka-Mieszkowska, A.; Jukkola-Vuorinen, A.; Rzepecka, I. K.; Pylkas, K.; Bidzinski, M.; Kauppila, S.; Hollestelle, A.; Seynaeve, C.; Tollenaar, R. A. E. M.; Durda, K.; Jaworska, K.; Hartikainen, J. M.; Kosma, V.M.; Kataja, V.; Antonenkova, N. N.; Long, J. R.; Shrubsole, M.; Deming-Halverson, S.; Lophatananon, A.; Siriwanarangsan, P.; Stewart-Brown, S.; Ditsch, N.; Lichtner, P.; Schmutzler, R. K.; Ito, H.; Iwata, H.; Tajima, K.; Tseng, C. C.; Stram, D. O.; van den Berg, D.; Yip, C. H.; Ikrarn, M. K.; Teh, Y. C.; Cai, H.; Lu, W.; Signorello, L. B.; Cai, Q. Y.; Noh, D. Y.; Yoo, K. Y.; Miao, H.; Iau, P. T. C.; Teo, Y. Y.; McKay, J.; Shapiro, C.; Ademuyiwa, F.; Fountzilas, G.; Hsiung, C. N.; Yu, J. C.; Hou, M. F.; Healey, C. S.; Luccarini, C.; Peock, S.; Stoppa-Lyonnet, D.; Peterlongo, P.; Rebbeck, T. R.; Piedmonte, M.; Singer, C. F.; Friedman, E.; Thomassen, M.; Offit, K.; Hansen, T. V. O.; Neuhausen, S. L.; Szabo, CI.; Blanco, I.; Garber, J.; Narod, S. A.; Weitzel, J. N.; Montagna, M.; Olah, E.; Godwin, A. K.; Yannoukakos, D.; Goldgar, D. E.; Caldes, T.; Imyanitov, E. N.; Tihomirova, L.; Arun, B. K.; Campbell, I.; Mensenkamp, A. R.; van Asperen, C. J.; van Roozendaa, K. E. P.; Meijers-Heijboer, H.; Collee, J. M.; Oosterwijk, J. C.; Hooning, M. J.; Rookus, M. A.; van der Luijt, R. B.; Os, T. A. M.; Evans, D. G.; Frost, D.; Fineberg, E.; Barwell, J.; Walker, L.; Kennedy, M. J.; Platte, R.; Davidson, R.; Ellis, S. D.; Cole, T.; Bressac-de Paillerets, B.; Buecher, B.; Damiola, F.; Faivre, L.; Frenay, M.; Sinilnikova, O. M.; Caron, O.; Giraud, S.; Mazoyer, S.; Bonadona, V.; Caux-Moncoutier, V.; Toloczko-Grabarek, A.; Gronwald, J.; Byrski, T.; Spurdle, A. B.; Bonanni, B.; Zaffaroni, D.; Giannini, G.; Bernard, L.; Dolcetti, R.; Manoukian, S.; Arnold, N.; Engel, C.; Deissler, H.; Rhiem, K.; Niederacher, D.; Pendl, H.; Sutter, C.; Wappenschmidt, B.; Borg, A.; Mein, B.; Rantala, J.; Soller, M.; Nathanson, K. L.; Domchek, S. M.; Rodríguez, G. C.; Salani, R.; Kaulich, D. G.; Tea, M. K.; Paluch, S. S.; Laitman, Y.; Skytte, A. B.; Kruse, T. A.; Jensen, U. B.; Robson, M.; Gerdes, A. M.; Ejlertsen, B.; Foretova, L.; Savage, S. A.; Lesterm, J.; Soucy, P.; Kuchenbaecker, K. B.; Olswold, C.; Cunningham, J. M.; Slager, S.; Pankratz, V. S.; Dicks, E.; Lakhani, S. R.; Couch, F. J.; Hall, P.; Monteiro, A. N. A.; Gayther, S. A.; Pharoah, P. D. P.; Reddel, R. R.; Goode, E. L.; Greene, M. H.; Easton, D. F.; Berchuck, A.; Antoniou, A. C.; Chenevix-Trench, G.; Dunning, A. M. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast
and ovarian cancer. 2013; 45(4): 371-384. NATURE GENETICS. Artículo. |
29,648 |
D1 |
|
2013 |
Cortés-Sempere, M.; de Miguel, M. P.; Pernía, O.; Rodríguez, C.; Carpeño, J. D.; Nistal, M.; Conde, E.; López-Ríos, F.; Belda-Iniesta, C.; Perona, R.; de Cáceres, I. I. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. ONCOGENE. 2013; 32(10): 1274-1283. Artículo. |
8,559 |
D1 |
|
2013 |
Sánchez-Aragó, M.; Formentini, L.; Martínez-Reyes, I.; García-Bermúdez, J.; Santacatterina, F.; Sánchez-Cenizo, L.; Willers, I. M.; Aldea, M.; Najera, L.; Juarranz, A.; López, E. C.; Clofent, J.; Navarro, C.; Espinosa, E.; Cuezva, J. M. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. ONCOGENESIS. 2013; 2: e46. Artículo. |
No Indexado |
No Indexado |
|
2013 |
de la Cueva, A.; de Molina, A. R.; Álvarez-Ayerza, N.; Ramos, M. A.; Cebrián, A.; del Pulgar, T. G.; Lacal, J. C. Combined 5-FU and choK alpha inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts. PLOS ONE. 2013; 8(6): e64961. Artículo. |
3,534 |
Q1 |
|
2013 |
Casado-Vela, J.; Lacal, J. C.; Elortza, F. Protein chimerism: novel
source of protein diversity in humans adds complexity to bottom-up proteomics. PROTEOMICS. 2013; 13(1): 5-11. Artículo. |
3,973 |
Q1 |
|
2013 |
Gámez-Pozo, A.; Ferrer, N. I.; Ciruelos, E.; López-Vacas, R.; Martínez, F. G.; Espinosa, E.; Vara, J. A. F. Shotgun proteomics of archival triple-negative breast cancer samples. PROTEOMICS CLINICAL APPLICATIONS. 2013; 7(3-4): 283-291. Artículo. |
2,683 |
Q2 |
|
2013 |
Molina, R.; Feliu, J. The return to work of cancer survivors: the experience in Spain. WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION. 2013; 46(4): 417-422. Artículo. |
No Indexado |
No Indexado |
|
2013 |
Feliu, J.; Espinosa, E. Should be NICE have a Spanish NICE? CLINICAL & TRANSLATIONAL ONCOLOGY. 2013; 15(7): 501-
502. Material Editorial. |
1,6 |
Q4 |
|
2013 |
de Dosso, S.; Grande, E.; Barriuso, J.; Castellano, D.; Tabernero, J.; Capdevila, J. The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation. CANCER AND METASTASIS REVIEWS. 2013; 32(3-4): 465-477. Revisión. |
6,449 |
D1 |
|
2013 |
Custodio, A.; Barriuso, J.; de Castro, J.; Martínez-Marín, V.; Moreno, V.; Rodríguez-Salas, N.; Feliu, J. Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives. CANCER TREATMENT REVIEWS. 2013; 39(8): 908-924. Revisión. |
6,466 |
D1 |
|
2013 |
Lamarca, A.; Moreno, V.; Feliu, J. Thymoma and thymic carcinoma
in the target therapies era. CANCER TREATMENT REVIEWS. 2013; 39(5): 413-420. Revisión. |
6,466 |
D1 |
|
2013 |
Custodio, A.; Feliú, J. Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal
cancer: beyond KRAS mutations. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2013; 85(1): 45-81. Revisión. |
4,046 |
Q2 |
|
2013 |
Hindi, N.; Cordero, N.; Espinosa, E. Thromboembolic disease in cancer patients. SUPPORTIVE CARE IN CANCER. 2013; 21(5): 1481-1486. Revisión. |
2,495 |
Q1 |
|
2012 |
Lamarca, A.; Barriuso J. Urine telomerase for diagnosis and surveillance of bladder cancer. ADVANCES IN UROLOGY. 2012; 2012: 693631. Article. |
No tiene |
No tiene |
|
2012 |
Lamarca, A.; Hindi, N.; Belda-Iniesta, C.; de Castro, J. Foot pain: uncommon presentation of lung cancer. BMJ CASE REPORTS. 2012; 2012: 1220115360. Article. |
No tiene |
No tiene |
|
2012 |
Warren, H.; Dudbridge, F.; Fletcher, O.; Orr, N.; Johnson, N.; Hopper, J. L.; Apicella, C.; Southey, M. C.; Mahmoodi M.; Schmidt, M. K.; Broeks, A.; Cornelissen, S.; Braaf, L. M.; Muir, K. R.; Lophatananon, A.; Chaiwerawattana, A.; Wiangnon, S.; Fasching, P. A.; Beckmann, M. W.; Ekici, A. B.; Schulz-Wendtland, R.; Sawyer, E. J.; Tomlinson, I.; Kerin, M.; Burwinkel, B.; Marme, F.; Schneeweiss, A.; Sohn, C.; Guenel, P.; Truong, T.; Laurent-Puig, P.; Mulot, C.; Bojesen, S. E.; Nielsen, S. F.; Flyger, H.; Nordestgaard, B. G.; Milne, R. L.; Benítez, J.; Arias-Pérez, J. I.; Zamora, M. P.; Antón-Culver, H.; Ziogas, A.; Bernstein, L.; Dur, C. C.; Brenner, H.; Muller, H.; Arndt, V.; Langheinz, A.; Meindl, A.; Golatta, M.; Bartram, C.R.; Schmutzler, R. K.; Brauch, H.; Justenhoven, C.; Bruning, T.; Chang-Claude, J.; Wang-Gohrke, S.; Eilber, U.; Dork, T.; Schurmann, P.; Bremer, M.; Hillemanns, P.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Bogdanova, N.; Antonenkova, N.; Rogov, Y.; Bermisheva, M.; Prokofyeva, D.; Zinnatullina, G.; Khusnutdinova, E.; Lindblom, A.; Margolin, S.; Mannermaa, A.; Kosma, V. M.; Hartikainen, J. M.; Kataja, V.; Chenevix-Trench, G.; Beesley, J.; Chen, X. Q.; Lambrechts, D.; Smeets, A.; Paridaens, R.; Weltens, C.; Flesch-Janys, D.; Buck, K.; Behrens, S.; Peterlongo, P.; Bernard, L.; Manoukian, S.; Radice, P.; Couch, F. J.; Vachon, C.; Wang, X. S.; Olson, J.; Giles, G.; Baglietto, L.; McLean, C. A.; Severi, G.; John, E. M.; Mirón, A.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Andrulis, I. L.; Knight, J. A.; Mulligan, A. M.; Weerasooriya, N.; Devilee, P.; Tollenaar, R. A. E. M.; Martens, J.W. M.; Seynaeve, C. M.; Hooning, M. J.; Hollestelle, A.; Jager, A.; Tilanus-Linthorst, M. M. A.; Hall, P.; Czene, K.; Liu, J.J.; Li, J. M.; Cox, A.; Cross, S. S.; Brock, I. W.; Reed, M. W. R.; Pharoah, P.; Blows, F. M.; Dunning, A. M.; Ghous-saini, M.; Ashworth, A.; Swerdlow, A.; Jones, M.; Schoemaker, M.; Easton, D. F.; Humphreys, M.; Wang, Q.; Peto, J.; dos-Santos-Silva, I. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2012; 21(10): 1783-1791. Article. |
4,559 |
D1 |
|
2012 |
Stevens, K. N.; Fredericksen, Z.; Vachon, C. M.; Wang, X. S.; Margolin, S.; Lindblom, A.; Nevanlinna, H.; Greco, D.; Aittomaki, K.; Blomqvist, C.; Chang-Claude, J.; Vrieling, A.; Flesch-Janys, D.; Sinn, H. P.; Wang-Gohrke, S.; Nickels, S.; Brauch, H.; Ko, Y. D.; Fischer, H. P.; Schmutzler, R. K.; Meindl, A.; Bartram, C. R.; Schott, S.; Engel, C.; Godwin, A. K.; Weaver, J.; Pathak, H. B.; Sharma, P.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Mirón, P.; Yannoukakos, D.; Stavropoulou, A.; Fountzilas, G.; Gogas, H. J.; Swann, R.; Dwek, M.; Perkins, A.; Milne, R. L.; Benítez, J.; Zamora, M. P.; Pérez, J. I. A.; Bojesen, S. E.; Nielsen, S. F.; Nordestgaard, B. G.; Flyger, H.; Guenel, P.; Truong, T.; Menegaux, F.; Cordina-Duverger, E.; Burwinkel, B.; Marme, F.; Schneeweiss, A.; Sohn, C.; Sawyer, E.; Tomlinson, I.; Kerin, M. J.; Peto, J.; Johnson, N.; Fletcher, O.; Silva, I. D.; Fasching, P. A.; Beckmann, M. W.; Hartmann, A.; Ekici, A. B.; Lophatananon, A.; Muir, K.; Puttawibul, P.; Wiangnon, S.; Schmidt, M. K.; Broeks, A.; Braaf, L. M.; Rosenberg, E. H.; Hopper, J. L.; Apicella, C.; Park, D. J.; Southey, M. C.; Swerdlow, A. J.; Ashworth, A.; Orr, N.; Schoemaker, M.J.; Antón-Culver, H.; Ziogas, A.; Bernstein, L.; Dur, C. C.; Shen, C. Y.; Yu, J. C.; Hsu, H. M.; Hsiung, C. N.; Hamann, U.; Dunnebier, T.; Rudiger, T.; Ulmer, H. U.; Pharoah, P. P.; Dunning, A.M.; Humphreys, M. K.; Wang, Q.; Cox, A.; Cross, S. S.; Reed, M. W.; Hall, P.; Czene, K.; Ambrosone, C. B.; Ademuyiwa, F.; Hwang, H.; Eccles, D. M.; García-Closas, M.; Figueroa, J.D.; Sherman, M. E.; Lissowska, J.; Devilee, P.; Seynaeve, C.; Tollenaar, R. A. E. M.; Hooning, M. J.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; John, E. M.; Mirón, A.; Alnaes, G. G.; Kristensen, V.; Borresen-Dale, A. L.; Giles, G. G.; Baglietto, L.; McLean, C. A.; Severi, G.; Kosel, M. L.; Pankratz, V.S.; Slager, S.; Olson, J. E.; Radice, P.; Peterlongo, P.; Manoukian, S.; Barile, M.; Lambrechts, D.; Hatse, S.; Dieudonne, A. S.; Christiaens, M. R.; Chenevix-Trench, G.; Beesley, J.; Chen, X. Q.; Mannermaa, A.; Kosma, V. M.; Hartikainen, J. M.; Soini, Y.; Easton, D. F.; Couch, F.J. 19p13.1 Is a triplenegative-specifi c breast cancer susceptibility locus. CANCER RESEARCH. 2012; 72(7): 1795-1803. Article. |
8,65 |
D1 |
|
2012 |
Garrido, P.; de Castro, J.; Concha, A.; Felip, E.; Isla, D.; López-Ríos, F.; Paz-Ares, L.; Ramírez, J.; Sanz, J.; Gómez, J. J. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). CLINICAL & TRANSLATIONAL ONCOLOGY. 2012; 14(5): 338-349. Article. |
1,276 |
Q4 |
|
2012 |
López-Gómez, M.; Cejas, P.; Merino, M.; Fernández-Luengas, D.; Casado, E.; Feliu, J. Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?. CLINICAL & TRANSLATIONAL ONCOLOGY. 2012; 14(9): 641-658. Article. |
1,276 |
Q4 |
|
2012 |
Fasching, P. A.; Pharoah, P. D. P.; Cox, A.; Nevanlinna, H.; Bojesen, S. E.; Karn, T.; Broeks, A.; van Leeuwen, F. E.; van ‘t Veer, L. J.; Udo, R.; Dunning, A. M.; Greco, D.; Aittomaki, K.; Blomqvist, C.; Shah, M.; Nordestgaard, B. G.; Flyger, H.; Hopper, J. L.; Southey, M. C.; Apicella, C.; García-Closas, M.; Sherman, M.; Lissowska, J.; Seynaeve, C.; Huijts, P. E. A.; Tollenaar, R. A. E. M.; Ziogas, A.; Ekici, A. B.; Rauh, C.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Andrulis, I. L.; Ozcelik, H.; Mulligan, A. M.; Glendon, G.; Hall, P.; Czene, K.; Liu, J. J.; Chang-Claude, J.; Wang-Gohrke, S.; Eilber, U.; Nickels, S.; Doerk, T.; Schiekel, M.; Bremer, M.; Park-Simon, T.W.; Giles, G. G.; Severi, G.; Baglietto, L.; Hooning, M. J.; Martens, J. W. M.; Jager, A.; Kriege, M.; Lindblom, A.; Margolin, S.; Couch, F. J.; Stevens, K. N.; Olson, J. E.; Kosei, M.; Cross, S. S.; Balasubramanian, S. P.; Reed, M. W. R.; Mirón, A.; John, E. M.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Kauppila, S.; Burwinkel, B.; Marme, F.; Schneeweiss, A.; Sohn, C.; Chenevix-Trench, G.; Lambrechts, D.; Dieudonne, A. S.; Hatse, S.; van Limbergen, E.; Benítez, J.; Milne, R. L.; Zamora, M. P.; Pérez, J. I. A.; Bonanni, B.; Peissel, B.; Loris, B.; Peterlongo, P.; Rajaraman, P.; Schonfeld, S. J.; Antón-Culver, H.; Devilee, P.; Beckmann, M. W.; Slamon, D. J.; Phillips, K. A.; Figueroa, J. D.; Humphreys, M. K.; Easton, D. F.; Schmidt, M. K.The role of genetic breast cancer susceptibility variants as prognostic factors. HUMAN MOLECULAR GENETICS. 2012; 21(17): 3926-3939. Article. |
7,692 |
D1 |
|
2012 |
Lambrechts, D.; Truong, T.; Justenhoven, C.; Humphreys, M.K.; Wang, J.; Hopper, J. L.; Dite, G. S.; Apicella, C.; Southey, M. C.; Schmidt, M. K.; Broeks, A.; Cornelissen, S.; van Hien, R.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Milne, R. L.; Zamora, M. P.; Pérez, J. I. A.; Benítez, J.; Hamann, U.; Ko, Y.D.; Bruning, T.; Chang-Claude, J.; Eilber, U.; Hein, R.; Nickels, S.; Flesch-Janys, D.; Wang-Gohrke, S.; John, E. M.; Mirón, A.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Chenevix-Trench, G.; Beesley, J.; Chen, X. Q.; Menegaux, F.; Cordina-Duverger, E.; Shen, C. Y.; Yu, J. C.; Wu, P. E.; Hou, M. F.; Andrulis, I. L.; Selander, T.; Glendon, G.; Mulligan, A.M.; Antón-Culver, H.; Ziogas, A.; Muir, K. R.; Lophatananon, N.; Ashworth, A.; Swerdlow, A.; Severi, G.; Baglietto, L.; Giles, G.; Southey, M.; Marme, F.; Schneeweiss, A.; Sohn, C.; Burwinkel, B.; Yesilyurt, B. T.; Neven, P.; Paridaens, R.; Wildiers, H.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Meindl, A.; Schott, S.; Bartram, C. R.; Schmutzler, R. K.; Cox, A.; Brock, I. W.; Elliott, G.; Cross, S. S.; Fasching, P. A.; Schulz-Wendtland, R.; Ekici, A. B.; Beckmann, M. W.; Fletcher, O.; Johnson, N.; Silva, I. D.; Peto, J.; Nevanlinna, H.; Muranen, T. A.; Aittomaki, K.; Blomqvist, C.; Dork, T.; Schurmann, P.; Bremer, M.; Hillemanns, P.; Bogdanova, N. V.; Antonenkova, N. N.; Rogov, Y. I.; Karstens, J. H.; Khusnutdinova, E.; Bermisheva, M.; Prokofi eva, D.; Gancev, S.; Jakubowska, A.; Lubinski, J.; Jaworska, K.; Durda, K.; Nordestgaard, B. G.; Bojesen, S. E.; Lanng, C.; Mannermaa, A.; Kataja, V.; Kosma, V. M.; Hartikainen, J. M.; Radice, P.; Peterlongo, P.; Manoukian, S.; Bernard, L.; Couch, F. J.; Olson, J. E.; Wang, X. S.; Fredericksen, Z.; Alnaes, G. G.; Kristensen, V.; Borresen-Dale, A. L.; Devilee, P.; Tollenaar, R. A. E. M.; Seynaeve, C.M.; Hooning, M. J.; García-Closas, M.; Chanock, S. J.; Lissowska, J.; Sherman, M. E.; Hall, P.; Liu, J. J.; Czene, K.; Kang, D.; Yoo, K. Y.; Noh, D. Y.; Lindblom, A.; Margolin, S.; Dunning, A. M.; Pharoah, P. D. P.; Easton, D. F.; Guenel, P.; Brauch, H. 11q13 is a susceptibility locus for hormone receptor positive breast cancer. HUMAN MUTATION. 2012; 33(7): 1123-1132. Article. |
5,213 |
Q1 |
|
2012 |
Sereno, M.; Cejas, P.; Moreno, V.; Belda-Iniesta, C.; López, R.; Nistal, M.; Feliu, J.; Carpeño, J.D. ERCC1 and topoisomerase I expression in small cell lung cancer: Prognostic and predictive implications. INTERNATIONAL JOURNAL OF ONCOLOGY. 2012; 40(6): 2104-2110. Article. |
2,657 |
Q2 |
|
2012 |
Casado, E.; García, V. M.; Sánchez, J. J.; del Pulgar, M. T.G.; Feliu, J.; Maurel, J.; Castelo, B.; Rubio, J.; López, R. A. B.; García-Cabezas, M. A.; Burgos, E.; de Castro, J.; Belda-Iniesta, C.; López-Gómez, M.; Gómez-Raposo, C.; Zambrana, F.; Sereno, M.; Fernández-Martos, C.; Vázquez, P.; Lacal, J.C.; González-Barón, M.; Cejas, P. Upregulation of trefoil Factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012; 84(5): 1151-1158. Article. |
4,524 |
D1 |
|
2012 |
Kirchhoff, T.; Gaudet, M. M.; Antoniou, A. C.; McGuffog, L.; Humphreys, M. K.; Dunning, A. M.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Kang, D.; Yoo, K. Y.; Noh, D. Y.; Ahn, S. H.; Dork, T.; Schurmann, P.; Karstens, J. H.; Hillemanns, P.; Couch, F. J.; Olson, J.; Vachon, C.; Wang, X. S.; Cox, A.; Brock, I.; Elliott, G.; Reed, M. W. R.; Burwinkel, B.; Meindl, A.; Brauch, H.; Hamann, U.; Ko, Y. D.; Broeks, A.; Schmidt, M. K.; van ‘t Veer, L. J.; Braaf, L. M.; Johnson, N.; Fletcher, O.; Gibson, L.; Peto, J.; Turnbull, C.; Seal, S.; Renwick, A.; Rahman, N.; Wu, P. E.; Yu, J. C.; Hsiung, C. N.; Shen, C. Y.; Southey, M. C.; Hopper, J. L.; Hammet, F.; Van Dorpe, T.; Dieudonne, A. S.; Hatse, S.; Lambrechts, D.; Andrulis, I. L.; Bogdanova, N.; Antonenkova, N.; Rogov, J. I.; Prokofi eva, D.; Bermisheva, M.; Khusnutdinova, E.; van Asperen, C. J.; Tollenaar, R. A. E. M.; Hooning, M. J.; Devilee, P.; Margolin, S.; Lindblom, A.; Milne, R. L.; Arias, J. I.; Zamora, M. P.; Benítez, J.; Severi, G.; Baglietto, L.; Giles, G. G.; Spurdle, A. B.; Beesley, J.; Chen, X. Q.; Holland, H.; Healey, S.; Wang-Gohrke, S.; Chang-Claude, J.; Mannermaa, A.; Kosma, V. M.; Kauppinen, J.; Kataja, V.; Agnarsson, B. A.; Caligo, M. A.; Godwin, A. K.; Nevanlinna, H.; Heikkinen, T.; Fredericksen, Z.; Lindor, N.; Nathanson, K. L.; Domchek, S. M.; Loman, N.; Karlsson, P.; Askmalm, M. S.; Melin, B.; von Wachenfeldt, A.; Hogervorst, F. B. L.; Verheus, M.; Rookus, M. A.; Seynaeve, C.; Oldenburg, R. A.; Ligtenberg, M. J.; Ausems, M. G. E. M.; Aalfs, C. M.; Gille, H. J. P.; Wijnen, J. T.; García, E. B. G.; Peock, S.; Cook, M.; Oliver, C. T.; Frost, D.; Luccarini, C.; Pichert, G.; Davidson, R.; Chu, C.; Eccles, D.; Ong, K. R.; Cook, J.; Douglas, F.; Hodgson, S.; Evans, D. G.; Eeles, R.; Gold, B.; Pharoah, P. D. P.; Offi t, K.; Chenevix-Trench, G.; Easton, D.F. Breast cancer risk and 6q22.33: combined results from breast cancer association consortium and consortium of investigators on modifi ers of BRCA1/2. PLOS ONE. 2012; 7(6): e35706. Article. |
3,73 |
Q1 |
|
2012 |
Hein, R.; Maranian, M.; Hopper, J. L.; Kapuscinski, M. K.; Southey, M. C.; Park, D. J.; Schmidt, M. K.; Broeks, A.; Hogervorst, F. B. L.; Bueno de Mesquit, H. B.; Muir, K. R.; Lophatananon, A.; Rattanamongkongul, S.; Puttawibul, P.; Fasching, P. A.; Hein, A.; Ekici, A. B.; Beckmann, M. W.; Fletcher, O.; Johnson, N.; Silva, I. D.; Peto, J.; Sawyer, E.; Tomlinson, I.; Kerin, M.; Miller, N.; Marmee, F.; Schneeweiss, A.; Sohn, C.; Burwinkel, B.; Guenel, P.; Cordina-Duverger, E.; Menegaux, F.; Truong, T.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Milne, R. L.; Pérez, J. I. A.; Zamora, M. P.; Benítez, J.; Antón-Culver, H.; Ziogas, A.; Bernstein, L.; Clarke, C. A.; Brenner, H.; Muller, H.; Arndt, V.; Stegmaier, C.; Rahman, N.; Seal, S.; Turnbull, C.; Renwick, A.; Meindl, A.; Schott, S.; Bartram, C. R.; Schmutzler, R. K.; Brauch, H.; Hamann, U.; Ko, Y. D.; Wang-Gohrke, S.; Dork, T.; Schurmann, P.; Karstens, J. H.; Hillemanns, P.; Nevanlinna, H.; Heikkinen, T.; Aittomaki, K.; Blomqvist, C.; Bogdanova, N. V.; Zalutsky, I. V.; Antonenkova, N. N.; Bermisheva, M.; Prokovieva, D.; Farahtdinova, A.; Khusnutdinova, E.; Lindblom, A.; Margolin, S.; Mannermaa A.; Kataja, V.; Kosma, V. M.; Hartikainen, J.; Chen, X.Q.; Beesley, J.; Lambrechts, D.; Zhao, H.; Neven, P.; Wildiers, H.; Nickels, S.; Flesch-Janys, D.; Radice, P.; Peterlongo, P.; Manoukian, S.; Barile, M.; Couch, F. J.; Olson, J. E.; Wang, X.S.; Fredericksen, Z.; Giles, G. G.; Baglietto, L.; McLean, C. A.; Severi, G.; Offi t, K.; Robson, M.; Gaudet, M. M.; Vijai, J.; Alnaes, G. G.; Kristensen, V.; Borresen-Dale, A. L.; John, E. M.; Mirón, A.; Winqvist, R.; Pylkas, K.; Jukkola-Vuorinen, A.; Grip, M.; Andrulis, I. L.; Knight, J. A.; Glendon, G.; Mulligan, A. M.; Figueroa, J. D.; García-Closas, M.; Lissowska, J.; Sherman, M. E.; Hooning, M.; Martens, J. W. M.; Seynaeve, C.; Collee, M.; Hall, P.; Humpreys, K.; Czene, K.; Liu, J. J.; Cox, A.; Brock, I. W.; Cross, S. S.; Reed, M. W. R.; Ahmed, S.; Ghoussaini, M.; Pharoah, P. D. P.; Kang, D.; Yoo, K. Y.; Noh, D. Y.; Jakubowska, A.; Jaworska, K.; Durda, K.; Zlowocka, E.; Sangrajrang, S.; Gaborieau, V.; Brennan, P.; McKay, J.; Shen, C. Y.; Yu, J. C.; Hsu, H. M.; Hou, M. F.; Orr, N.; Schoemaker, M.; Ashworth, A.; Swerdlow, A.; Trentham-Dietz, A.; Newcomb, P. A.; Titus, L.; Egan, K. M.; Chenevix-Trench, G.; Antoniou, A. C.; Humphreys, M. K.; Morrison, J.; Chang-Claude, J.; Easton, D. F.; Dunning, A. M. Comparison of 6q25 breast cancer hits from asian and european genome wide association studies in the breast cancer association consortium (BCAC). PLOS ONE. 2012; 7(8): e42380. Article. |
3,73 |
Q1 |
|
2012 |
Gámez-Pozo, A.; Sánchez-Navarro, I.; Calvo, E.; Agullo-Ortuno, M. T.; López-Vacas, R.; Díaz, E.; Camafeita, E.; Nistal, M.; Madero, R.; Espinosa, E.; López, J. A.; Vara, J. A. F. PTRF/Cavin-1 and MIF proteins are identifi ed as non-small cell lung cancer biomarkers by label-free proteomics. PLOS ONE. 2012; 7(3): e33752. Article. |
3,73 |
Q1 |
|
2012 |
Muñiz, N. H.; Lete, A. L.; Batlle, J. F. Hereditary colorectal cáncer. MEDICINA CLÍNICA. 2012; 138(5): 220-223. Editorial Material. |
1,399 |
Q2 |
|
2012 |
Grande, E.; Capdevila, J.; Barriuso, J.; Antón-Aparicio, L.; Castellano, D. Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?. CANCER AND METASTASIS REVIEWS. 2012; 31(1-feb): 47-53. Review. |
7,787 |
D1 |
|
2012 |
Espinosa, E.; Gámez-Pozo, A.; Sánchez-Navarro, I.; Pinto, A.; Castañeda, C. A.; Ciruelos, E.; Feliu, J.; Vara, J. A. F. The present and future of gene profi ling in breast cancer. CANCER AND METASTASIS REVIEWS. 2012; 31(1-feb): 41-46. Review. |
7,787 |
D1 |
|
2012 |
Cejas, P.; López-Gómez, M.; Aguayo, C.; Madero, R.; Moreno-Rubio, J.; Carpeño, J. D.; Belda-Iniesta, C.; Barriuso, J.; García, V. M.; Díaz, E.; Burgos, E.; González-Barón, M.; Feliu, J. Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients: implications for cancer therapy. CURRENT CANCER DRUG TARGETS. 2012; 12(2): 124-131. Review. |
4 |
Q2 |
|
2012 |
Arranz, E. E.; Vara, J. A. F.; Gámez-Pozo, A.; Zamora, P. Gene signatures in breast cancer: current and future uses. TRANSLATIONAL
ONCOLOGY. 2012; 5(6): 398-403. Review. |
2,943 |
Q2 |
|
2012 |
Salas, N. R.; Cubillo, A. Resected duodenal gastrointestinal stromal tumour with an affected margin and exon 9 mutation: adjuvant therapy. ANTI-CANCER DRUGS. PHARMACOLOGY & PHARMACY. 2012; 23(1): S18-S21. Article. |
2,232 |
Q2 |
|
2012 |
García, V. M.; Thavasu, P.; Codesido, M. B.; Molife, L. R.; Pedersen, J. V.; Puglisi, M.; Basu, B.; Shah, K.; Iqbal, J.; de Bono, J. S.; Kaye, S. B.; Banerji, U. Association of creatine kinase and skin toxicity in phase I trials of anticancer agents. BRITISH JOURNAL OF CANCER. 2012; 107(11): 1797-1800. Article. |
5,082 |
Q1 |
|
2012 |
Kaye, S.; Aamdal, S.; Jones, R.; Freyer, G.; Pujade-Lauraine, E.; de Vries, E. G. E.; Barriuso, J.; Sandhu, S.; Tan, D. S. W.; Hartog, V.; Kuenen, B.; Ruijter, R.; Kristensen, G. B.; Nyakas, M.; Barrett, S.; Burke, W.; Pietersma, D.; Stuart, M.; Emeribe, U.; Boven, E. Phase I study of Saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours. BRITISH JOURNAL OF CANCER. 2012; 106(11): 1728-1734. Article. |
5,082 |
Q1 |
|
2012 |
Kozloff, M. F.; Martín, L. P.; Krzakowski, M.; Samuel, T. A.; Rado, T. A.; Arriola, E. Carpeño, J. D.; Herbst, R. S.; Tarazi, J.; Kim, S.; Rosbrook, B.; Tortorici, M.; Olszanski, A. J.; Cohen, R.B. Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours. BRITISH JOURNAL OF CANCER. 2012; 107(8): 1277-1285. Article. |
5,082 |
Q1 |
|
2012 |
Espinosa, E.; Berrocal, A.; Martín, J. A. L.; Cao, M. G.; Cerezuela, P.; Mayordomo, J. I.; Algarra, S. M. Advances in cutaneous melanoma. CLINICAL & TRANSLATIONAL ONCOLOGY. 2012; 14(5): 325-332. Article. |
1,276 |
Q4 |
|
2012 |
Pinto, A.; Cruz, P. Radium-223 chloride: a new treatment option for metastatic castration-resistant prostate carcinoma. DRUGS IN RESEARCH AND DEVELOPMENT. 2012; 12(5): 227-233. |
No tiene |
No tiene |
|
2012 |
Vitfell-Pedersen, J.; Yap, T. A.; Moreno, V.; Baird, R. D.; Khan, A. Z.; Barton, D. P. J.; Kaye, S. B. The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2012; 33(2): 211-213.Article. |
0,577 |
Q4 |
|
2012 |
Rosell, R.; Carcereny, E.; Gervais, R.; Vergnenegre, A.; Massuti, B.; Felip, E.; Palmero, R.; García-Gómez, R.; Pallares, C.; Sánchez, J. M.; Porta, R.; Cobo, M.; Garrido, P.; Longo, F.; Morán, T.; Insa, A.; de Marinis, F.; Corre, R.; Bover, I.; Illiano, A.; Dansin, E.; de Castro, J.; Milella, M.; Reguart, N.; Altavilla, G.; Jiménez, U.; Provencio, M.; Moreno, M. A.; Terrasa, J.; Muñoz-Langa, J.; Valdivia, J.; Isla, D.; Domine, M.; Molinier, O.; Mazieres, J.; Baize, N.; García-Campelo, R.; Robinet, G.; Rodríguez-Abreu, D.; López-Vivanco, G.; Gebbia, V.; Ferrera-Delgado, L.; Bombaron, P.; Bernabe, R.; Bearz, A.; Artal, A.;
Cortesi, E.; Rolfo, C.; Sánchez-Ronco, M.; Drozdowskyj, A.; Queralt, C.; de Aguirre, I.; Ramírez, J. L.; Sánchez, J. J.; Molina, M. A.; Tarón, M.; Paz-Ares, L. Erlotinib versus standard chemotherapy as fi rst-line treatment for european patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. LANCET ONCOLOGY. 2012; 13(3): 239-246. Article. |
25,117 |
D1 |
|
2012 |
Nuijten, M. J. C.; Carpeño, J. D.; Chouaid, C.; Vergnenegre, A.; Grossi, F.; Bischoff, H.; Heigener, D.; Walzer, S. A crossmarket cost comparison of erlotinib versus pemetrexed for fi rst-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer. LUNG CANCER. 2012; 76(3): 465-471. Article. |
3,392 |
Q1 |
|
2012 |
Schnabel, P. A.; Smit, E.; Carpeño, J. D.; Lesniewski-Kmak, K.; Aerts, J.; Kraaij, K.; Visseren-Grul, C.; Dyachkova, Y.; Taipale, K.; Girvan, A.; Moro-Sibilot, D. Infl uence of histology and biomarkers on fi rst-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME). LUNG CANCER. 2012; 78(3): 263-269. Article. |
3,392 |
Q1 |
|
2012 |
Gámez-Pozo, A.; Antón-Aparicio, L. M.; Bayona, C.; Borrega, P.; Sancho, M. I. G.; García-Domínguez, R.; de Portugal, T.; Ramos-Vázquez, M.; Pérez-Carrión, R.; Bolos, M. V.; Madero, R.; Sánchez-Navarro, I.; Vara, J. A. F.; Arranz, E. E. MicroRNA expression profi ling of peripheral blood samples predicts resistance to fi rst-line sunitinib in advanced renal cell carcinoma patients. NEOPLASIA. 2012; 14(12): 1144-1152. Article. |
5,47 |
Q1 |
|
2012 |
Basu, B.; Vitfell-Pedersen, J.; García, V. M.; Puglisi, M.; Tjokrowidjaja, A.; Shah, K.; Malvankar, S.; Anghan, B.; de Bono, J. S.; Kaye, S. B.; Molife, L. R.; Banerji, U. Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials. ONCOLOGY. 2012; 83(4): 177-182. Article. |
2,165 |
Q3 |
|
2012 |
Feliu, J.; González-Montalvo, J. I. Controversies in the management
of breast cancer in women of advanced age. REVISTA ESPAÑOLA DE GERONTOLOGÍA Y GERIATRÍA. 2012; 47(5): 191-192. |
No tiene |
No tiene |
|
2012 |
Lamarca, A.; Feliu, J.; Barriuso, J. Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma. BRITISH JOURNAL OF CANCER. 2012; 106(6): 1246-1246. Letter. |
5,082 |
Q1 |
|
2012 |
Larriba, J. L. G.; Espinosa, E.; Carbonero, I. G.; García-Donas, J.; López, M.; Meana, A.; Puente, J.; Bellmunt, J. Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action. CANCER AND METASTASIS REVIEWS. 2012; 31(1): S11-S17. Review. |
7,787 |
D1 |
|
2012 |
Pintzas, A.; Zhivotovsky, B.; Workman, P.; Clarke, P. A.; Linardopoulos,
S.; Martinou, J. C.; Lacal, J. C.; Robine, S.; Nasioulas, G.; Andera, L. Sensitization of (colon) cancer cells to death receptor related therapies A report from the FP6-ONCODEATH research consortium. CANCER BIOLOGY & THERAPY. 2012; 13(7): 458-466. Review. |
3,287 |
Q2 |
|
2012 |
Custodio, A.; Méndez, M.; Provencio, M. Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications. CANCER TREATMENT REVIEWS. 2012; 38(1): 36-53. Review. |
6,024 |
Q1 |
|
2012 |
García, V. M.; Basu, B.; Molife, L. R.; Kaye, S. B. Combining antiangiogenics to overcome resistance: rationale and clinical experience. CLINICAL CANCER RESEARCH. 2012; 18(14): 3750-3761. Review. |
7,837 |
D1 |
|
2012 |
Custodio, A.; de Castro, J. Strategies for maintenance therapy in advanced non-small cell lung cancer: Current status, unanswered questions and future directions. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2012; 82 (3): 338-360. Review. |
4,637 |
Q1 |
|
2012 |
de Molina, A. R.; de la Cueva, A.; Machado-Pinilla, R.; Rodríguez-Fanjul, V.; del Pulgar, T. G.; Cebrián, A.; Perona, R.; Lacal, J. C. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase alpha inhibition. CURRENT CANCER DRUG TARGETS. 2012; 12 (6): 617-624. Review. |
4 |
Q2 |
|
2012 |
Fernández-Martos, C.; Nogue, M.; Cejas, P.; Moreno-García, V.; Machancoses, A. H.; Feliu, J. The role of capecitabine in locally advanced rectal cancer treatment an update. DRUGS. 2012; 72(8): 1057-1073. Review. |
4,633 |
D1 |
|
2012 |
Pinto, A.; Merino, M.; Zamora, P.; Redondo, A.; Castelo, B.; Espinosa, E. Targeting the endothelin axis in prostate carcinoma. TUMOR BIOLOGY. 2012; 33(2): 421-426. Review. |
2,518 |
Q3 |
|
2012 |
Marín, A. P.; Sánchez, A. R.; Arranz, E. E.; Auñón, P. Z.; Fernández,
B. C.; Barón, M. G. MTOR pathway inhibition in renal cell carcinoma. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2012; 30(4): 356-361. Review. |
3,647 |
Q1 |
|
2012 |
López-Gómez, M.; Ortega, C.; Suárez, I.; Serralta, G.; Madero, R.; Gómez-Raposo, C.; Sereno, M.; Casado, E.; Espinosa, E.; Lobo, F.; Feliu, J. Internet use by cancer patients: should oncologists ‘prescribe’ accurate web sites in combination with chemotherapy? A survey in a Spanish cohort. ANNALS OF ONCOLOGY. 2012; 23(6): 1579-1585. Article. |
7,384 |
D1 |
|
2012 |
Langa, J. M.; Gascón, P.; de Castro, J. SEOM clinical guidelines for myeloid growth factors. CLINICAL & TRANSLATIONAL ONCOLOGY. 2012; 14(7): 491-498. Article. |
1,276 |
Q4 |
|
2012 |
Custodio, A.; López-Farre, A. J.; Zamorano-León, J. J.; Mateos-Cáceres, P. J.; Macaya, C.; Caldes, T.; de la Hoya, M.; Olivera, E.; Puente, J.; Díaz-Rubio, E.; Pérez-Segura, P. Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2012; 138(5): 867-875. Article. |
2,914 |
Q2 |
|
2012 |
Martínez-Hernández, P. L.; Hernanz-Macías, A.; Gómez-Candela,
C.; Grande-Aragón, C.; Feliu-Batlle, J.; Castro-Carpeño, J.; Martínez-Muñoz, I.; Zurita-Rosa, L.; Villarino-Sanz, M.; Prados-Sanchez, C.; García-Girón, J. S. Serum interleukin-15 levels in cancer patients with cachexia. ONCOLOGY REPORTS. 2012; 28(4): 1443-1452. Article. |
2,297 |
Q3 |
|
2011 |
Gallego-Ortega, D.; del Pulgar, T. G.; Valdés-Mora, F.; Cebrián, A.;
Lacal, J. C. Involvement of human choline kinase alpha and beta
in carcinogenesis: A different role in lipid metabolism and biological
functions. ADVANCES IN ENZYME REGULATION. 2011;
51: 183-194. Article. |
No tiene |
No tiene |
|
2011 |
Villaronga, M. A.; López-Mateo, I.; Markert, L.; Espinosa, E.; Vara,
J. A. F.; Belandia, B. Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient. BREAST CANCER RESEARCH AND TREATMENT. 2011; 128(3): 891-898. Article. |
4,431 |
Q1 |
|
2011 |
Espinosa, E.; Vara, J. A. F.; Navarro, I. S.; Gámez-Pozo, A.; Pinto, A.; Zamora, P.; Redondo, A.; Feliú, J. Gene profiling in breast cancer: Time to move forward. CANCER TREATMENT REVIEWS. 2011; 37(6): 416-421.Review. |
6,054 |
Q1 |
|
2011 |
Casado-Vela, J.; Cebrián, A.; del Pulgar, M. T. G.; Lacal, J. C. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. CLINICAL & TRANSLATIONAL ONCOLOGY. 2011; 13(9): 617-628. Article. |
1,327 |
Q4 |
|
2011 |
Casado, E.; García, V. M.; Sánchez, J. J.; Blanco, M.; Maurel, J.; Feliú, J.; Fernández-Martos, C.; de Castro, J.; Castelo, B.; Belda-Iniesta, C.; Sereno, M.; Sánchez-Llamas, B.; Burgos, E.; García-Cabezas, M. A.; Mancenido, N.; Miquel, R.; García-Olmo, D.; González-Barón, M.; Cejas, P. A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer. CLINICAL CANCER RESEARCH. 2011; 17(12): 4145-4154. Article. |
7,742 |
D1 |
|
2011 |
García, V. M.; Batlle, J. F.; Casado, E.; Burgos, E.; de Castro, J.; Belda, C.; Barriuso, J.; Sánchez, J. J.; García-Cabezas, M. A.; González-Barón, M.; Cejas, P. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy. COLORECTAL DISEASE. 2011; 13(9): 989-998. Article. |
2,927 |
Q2 |
|
2011 |
Castañeda, C. A.; Agullo-Ortuno, M. T.; Vara, J. A. F.; Cortes-Funes H.; Gómez, H. L.; Ciruelos, E. Implication of miRNA in the diagnosis and treatment of breast cancer. EXPERT REVIEW OF ANTICANCER THERAPY. 2011; 11(8): 1265-1275. Review. |
2,652 |
Q2 |
|
2011 |
Casado-Vela, J.; del Pulgar, T. G.; Cebrián, A.; Álvarez-Ayerza, N.; Lacal, J. C. Human urine proteomics: building a list of human urine cancer biomarkers. EXPERT REVIEW OF PROTEOMICS. 2011; 8(3): 347-360. Review. |
3,685 |
Q2 |
|
2011 |
Broeks, A.; Schmidt, M. K.; Sherman, M. E.; Couch, F. J.; Hopper,
J. L.; Dite, G. S.; Apicella, C.; Smith, L. D.; Hammet, F.; Southey, M. C.; Van ‘t Veer, L. J.; de Groot, R.; Smit, V. T. H. B. M.; Fasching, P.
A.; Beckmann, M. W.; Jud, S.; Ekici, A. B.; Hartmann, A.; Hein, A.;
Schulz-Wendtland, R.; Burwinkel, B.; Marme, F.; Schneeweiss, A.;
Sinn, H. P.; Sohn, C.; Tchatchou, S.; Bojesen, S. E.; Nordestgaard, B. G.; Flyger, H.; Orsted, D. D.; Kaur-Knudsen, D.; Milne, R. L.; Perez, J. I. A.; Zamora, P.; Rodríguez, P. M.; Benítez, J.; Brauch, H.; Justenhoven, C.; Ko, Y. D.; Hamann, U.; Fischer, H. P.; Bruning, T.; Pesch, B.; Chang-Claude, J.; Wang-Gohrke, S.; Bremer, M.; Karstens, J. H.; Hillemanns, P.; Dork, T.; Nevanlinna, H. A.; Heikkinen, T.; Heikkila, P.; Blomqvist, C.; Aittomaki, K.; Aaltonen, K.; Lindblom, A.; Margolin, S.; Mannermaa, A.; Kosma, V. M.; Kauppinen, J. M.; Kataja, V.; Auvinen, P.; Eskelinen, M.; Soini, Y.; Chenevix-Trench, G.; Spurdle, A. B.; Beesley, J.; Chen, X. Q.; Holland, H.; Lambrechts, D.; Claes, B.; Vandorpe, T.; Neven, P.; Wildiers, H.; Flesch-Janys, D.; Hein, R.; Loning, T.; Kosel, M.; Fredericksen, Z. S.; Wang, X. S.; Giles, G. G.; Baglietto, L.; Severi, G.; McLean, C.; Haiman, C. A.; Henderson, B. E.; Le Marchand, L.; Kolonel, L. N.; Alnaes, G. G.; Kristensen, V.; Borresen-Dale, A. L.; Hunter, D. J.; Hankinson, S. E.; Andrulis, I. L.; Mulligan, A. M.; O’Malley, F. P.; Devilee, P.; Huijts, P. E. A.; Tollenaar, R. A. E. M.; Van Asperen, C. J.; Seynaeve, C. S.; Chanock, S. J.; Lissowska, J.; Brinton, L.; Peplonska, B.; Figueroa, J.; Yang, X. H. R.; Hooning, M. J.; Hollestelle, A.; Oldenburg, R. A.; Jager, A.; Kriege, M.; Ozturk, B.; van Leenders, G. J. L. H.; Hall, P.; Czene, K.; Humphreys, K.; Liu, J. J.; Cox, A.; Connley, D.; Cramp, H. E.; Cross, S. S.; Balasubramanian, S. P.; Reed, M. W. R.; Dunning, A. M.; Easton, D. F.; Humphreys, M. K.; Caldas, C.; Blows, F.; Driver, K.; Provenzano, E.; Lubinski, J.; Jakubowska, A.; Huzarski, T.; Byrski, T.; Cybulski, C.; Gorski, B.; Gronwald, J.; Brennan, P.; Sangrajrang, S.; Gaborieau, V.; Shen, C. Y.; Hsiung, C. N.; Yu, J. C.; Chen, S. T.; Hsu, G. C.; Hou, M. F.; Huang, C. S.; Anton-Culver, H.; Ziogas, A.; Pharoah, P. D. P.; García-Closas, M. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. HUMAN MOLECULAR GENETICS. 2011; 20(16): 3289-3303. Article. |
7,636 |
D1 |
|
2011 |
Alonso-Babarro, A.; Bruera, E.; Varela-Cerdeira, M.; Boya-Cristia, M. J.; Madero, R.; Torres-Vigil, I.; De Castro, J.; González-Barón, M. Can This Patient Be Discharged Home? Factors Associated With At-Home Death Among Patients With Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2011; 29(9): 1159-1167. Article. |
18,372 |
D1 |
|
2011 |
Jiménez, A.; Madero, R.; Alonso, A.; Martínez-Marín, V.; Vilches, Y.; Martínez, B.; Feliú, M.; Díaz, L.; Espinosa, E.; Feliú, J. Symptom Clusters in Advanced Cancer. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2011; 42(1): 24-31. Article. |
2,503 |
Q1 |
|
2011 |
Belda-Iniesta, C.; de Castro, J.; Perona, R. Translational Proteomics:
What Can You Do for True Patients? JOURNAL OF PROTEOME
RESEARCH. 2011; 10(1): 101-104. Editorial Material. |
5,113 |
Q1 |
|
2011 |
Yang, X. R.; Chang-Claude, J.; Goode, E. L.; Couch, F. J.; Nevanlinna, H.; Milne, R. L.; Gaudet, M.; Schmidt, M. K.; Broeks, A.; Cox, A.; Fasching, P. A.; Hein, R.; Spurdle, A. B.; Blows, F.; Driver, K.; Flesch-Janys, D.; Heinz, J.; Sinn, P.; Vrieling, A.; Heikkinen, T.; Aittomaki, K.; Heikkila, P.; Blomqvist, C.; Lissowska, J.; Peplonska, B.; Chanock, S.; Figueroa, J.; Brinton, L.; Hall, P.; Czene, K.; Humphreys, K.; Darabi, H.; Liu, J. J.; Van ‘t Veer, L. J.; Van Leeuwen, F. E.; Andrulis, I. L.; Glendon, G.; Knight, J. A.; Mulligan, A. M.; O’Malley, F. P.; Weerasooriya, N.; John, E. M.; Beckmann, M. W.; Hartm ann, A.; Weihbrecht, S. B.; Wachter, D. L.; Jud, S. M.; Loehberg, C. R.; Baglietto, L.; English, D. R.; Giles, G. G.; McLean, C. A.; Severi, G.; Lambrechts, D.; Vandorpe, T.; Weltens, C.; Paridaens, R.; Smeets, A.; Neven, P.; Wildiers, H.; Wang, X. S.; Olson, J. E.; Cafourek, V.; Fredericksen, Z.; Kosel, M.; Vachon, C.; Cramp, H. E.; Connley, D.; Cross, S. S.; Balasubramanian, S. P.; Reed, M. W. R.; Dork, T.; Bremer, M.; Meyer, A.; Karstens, J. H.; Ay, A.; Park-Simon, T. W.; Hillemanns, P.; Pérez, J. I. A.; Rodríguez, P. M.; Zamora, P.; Bentez, J.; Ko, Y. D.; Fischer, H. P.; Hamann, U.; Pesch, B.; Bruning, T.; Justenhoven, C.; Brauch, H.; Eccles, D. M.; Tapper, W. J.; Gerty, S. M.; Sawyer, E. J.; Tomlinson, I. P.; Jones, A.; Kerin, M.; Miller, N.; McInerney, N.; Anton-Culver, H.; Ziogas, A.; Shen, C. Y.; Hsiung, C. N.; Wu, P. E.; Yang, S. L.; Yu, J. C.; Chen, S. T.; Hsu, G. C.; Haiman, C. A.; Henderson, B. E.; Le Marchand, L.; Kolonel, L. N.; Lindblom, A.; Margolin, S.; Jakubowska, A.; Lubinski, J.; Huzarski, T.; Byrski, T.; Gorski, B.; Gronwald, J.; Hooning, M. J.; Hollestelle, A.; van den Ouweland, A. M. W.; Jager, A.; Kriege, M.; Tilanus-Linthorst, M. M. A.; Collee, M.; Wang-Gohrke, S.; Pylkas, K.; Jukkola-Vuorinen, A.; Mononen, K.; Grip, M.; Hirvikoski, P.; Winqvist, R.; Mannermaa, A.; Kosma, V. M.; Kauppinen, J.; Kataja, V.; Auvinen, P.; Soini, Y.; Sironen, R.; Bojesen, S. E.; Orsted, D. D.; Kaur-Knudsen, D.; Flyger, H.; Nordestgaard, B. G.; Holland, H.; Chenevix-Trench, G.; Manoukian, S.; Barile, M.; Radice, P.; Hankinson, S. E.; Hunter, D. J.; Tamimi, R.; Sangrajrang, S.; Brennan, P.; Mckay, J.; Odefrey, F.; Gaborieau, V.; Devilee, P.; Huijts, P. E. A.; Tollenaar, R. A. E. M.; Seynaeve, C.; Dite, G. S.; Apicella, C.; Hopper, J. L.; Hammet, F.; Tsimiklis, H.; Smith, L. D.; Southey, M. C.; Humphreys, M. K.; Easton, D.; Pharoah, P.; Sherman, M. E.; García-Closas, M. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011; 103(3): 250-263. Article. |
13,757 |
D1 |
|
2011 |
Feliú, J.; Jiménez-Gordo, A. M.; Madero, R.; Rodríguez-Aizcorbe, J. R.; Espinosa, E.; Castro, J.; Acedo, J. D.; Martínez, B.; Alonso-Babarro, A.; Molina, R.; Camara, J. C.; García-Paredes, M. L.; González-Barón, M. Development and Validation of a Prognostic Nomogram for Terminally Ill Cancer Patients. JOURNAL OF THE NATIONAL CANCER
INSTITUTE. 2011; 103(21): 1613-1620. Article. |
13,757 |
D1 |
|
2011 |
Gámez-Pozo, A.; Sánchez-Navarro, I.; Calvo, E.; Díaz, E.; Miguel-Martín,
M.; López, R.; Agullo, T.; Camafeita, E.; Espinosa, E.; López, J. A.; Nistal, M.; Vara, J. A. F. Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches. MOLECULAR BIOSYSTEMS. 2011; 7(8): 2368-2374. Article. |
3,534 |
Q2 |
|
2011 |
Casado-Vela, J.; Cebrián, A.; del Pulgar, M. T. G.; Sánchez-López, E.;
Vilaseca, M.; Menchen, L.; Diema, C.; Selles-Marchart, S.; Martínez-
Esteso, M. J.; Yubero, N.; Bru-Martínez, R.; Lacal, J. C. Lights and shadows of proteomic technologies for the study of protein species
including isoforms, splicing variants and protein post-translational modifications. PROTEOMICS; 2011; 11(4): 590-603. Review. |
4,505 |
Q1 |
|
2011 |
García, V. M.; Cassier, P. A.; de Bono, J. Parallel Anticancer Drug Development and Molecular Stratification to Qualify Predictive Biomarkers:
Dealing with Obstacles Hindering Progress. CANCER DISCOVERY. 2011; 1(3): 207-212. IF - Article. |
No tiene |
No tiene |
|
2011 |
Perona, R.; López-Ayllón, B. D.; Carpeño, J. D.; Belda-Iniesta, C. A role for cancer stem cells in drug resistance and metastasis in nonsmall-cell lung cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 2011; 13(5): 289-293. Article. |
1,327 |
Q4 |
|
2011 |
de Paredes, M. L. G.; González, F. D.; del Prado, P. M.; Ciriquian, J. L. M.; Francés, S. E.; Dols, M. C.; González, E. E.; Granados, A. L. O.; Tarruella, M. M.; Burón, J. D. C.; Hernández, A.; Miranda, E. L.; Santos, J. P. C.; Carpeño, F. J. D. First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the on study. ANNALS OF ONCOLOGY. 2011; 22(4): 924-930. Article. |
6,425 |
D1 |
|
2011 |
Feliú, J.; Borrega, P.; León, A.; López-Gómez, L.; Lopez, M.; Castro, J.;
Belda-Iniesta, C.; Barriuso, J.; Martínez, V.; González-Barón, M. Phase
II study of a fixed dose-rate infusion of gemcitabine associated with
erlotinib in advanced pancreatic cancer. CANCER CHEMOTHERAP
AND PHARMACOLOGY. 2011; 67(1): 215-221. Article. |
2,833 |
Q2 |
|
2011 |
Feliú, J.; Sastre, J.; Maurel, J.; Isla, D. Hepatocellular and biliary tract
carcinomas: SEOM clinical guidelines. CLINICAL & TRANSLATIONAL
ONCOLOGY. 2011; 13(8): 536-544. Article. |
1,327 |
Q4 |
|
2011 |
Belda-Iniesta, C.; de Cáceres, I. I.; de Castro, J. Monoclonal antibodies
for medical oncology: a few critical perspectives. CLINICAL & TRANSLATIONAL ONCOLOGY. 2011; 13(2): 84-87. Article. |
1,327 |
Q4 |
|
2011 |
Maurel, J.; Fernández-Martos, C.; Feliú, J.; Isla, D. SEOM clinical guidelines for the treatment of anal cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 2011; 13(8): 525-527. Article. |
1,327 |
Q4 |
|
2011 |
Nuijten, M. J. C.; Aultman, R.; Carpeno, J. D.; Vergnenegre, A.; Chouaid,
C.; Walzer, S.; Siebert, U. An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer. CURRENT MEDICAL RESEARCH AND OPINION. 2011; 27(11): 2193-2201. Article. |
2,38 |
Q1 |
|
2011 |
Batlle, J. F.; Cuadrado, E.; Castro, J.; Caldes, T.; Belda, C.; Sastre, J.;
Barriuso, J.; Marín, V. M.; Díaz-Rubio, E.; González-Barón, M. Irinotecan-
Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study. CHEMOTHERAPY. 2011; 57(2): 138-144. Article. |
1,816 |
Q3 |
|
2011 |
Merino, M.; Pinto, A.; González, R.; Espinosa, E. Antiangiogenic agents
and endothelin antagonists in advanced castration resistant prostate cancer. EUROPEAN JOURNAL OF CANCER. 2011; 47(12): 1846-1851. Article. |
5,536 |
Q1 |
|
2011 |
Porta, R.; Sánchez-Torres, J. M.; Paz-Ares, L.; Massuti, B.; Reguart, N.;
Mayo, C.; Lianes, P.; Queralt, C.; Guillem, V.; Salinas, P.; Catot, S.; Isla, D.; Pradas, A.; Gurpide, A.; de Castro, J.; Polo, E.; Puig, T.; Taron, M.; Colomer, R.; Rosell, R. Brain metastases from lung cancer responding to
erlotinib: the importance of EGFR mutation. EUROPEAN RESPIRATORY
JOURNAL. 2011; 37(3): 624-631. Article. |
5,895 |
D1 |
|
2011 |
Feliú, J.; Barriuso, J. Reply: Capecitabine and bevacizumab as firstline
treatment in elderly patients with metastatic colorectal cancer. BRITISH JOURNAL OF CANCER.2011; 104(1): 226-226. Letter. |
5,042 |
Q1 |
|
2011 |
Vieitez, J. M.; García-Carbonero, R.; Aparicio, J.; Feliú, J.; González-
Flores, E.; Grande, E.; Pérez-Hoyos, T.; Salud, A.; Torres, E.; Valero, M.;
Valladares-Ayerbes, M.; Díaz-Rubio, E. Recommendations and expert
opinion on the adjuvant treatment of colon cancer in Spain. CLINICAL & TRANSLATIONAL ONCOLOGY. 2011; 13(11): 798-804. Article. |
1,327 |
Q4 |
|
2011 |
Olmos, D.; Barker, D.; Sharma, R.; Brunetto, A. T.; Yap, T. A.; Taegtmeyer, A. B.; Barriuso, J.; Medani, H.; Degenhardt, Y. Y.; Allred, A. J.; Smith, D. A.; Murray, S. C.; Lampkin, T. A.; Dar, M. M.; Wilson, R.; de Bono, J. S.; Blagden, S. P. Phase I Study of GSK461364, a Specific
and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies. CLINICAL CANCER RESEARCH. 2011; 17(10):
3420-3430. Article. |
7,742 |
D1 |
|
2011 |
Gridelli, C.; Bennouna, J.; de Castro, J.; Dingemans, A. M. C.; Griesinger, F.; Grossi, F.; Rossi, A.; Thatcher, N.; Wong, E. K.; Langer, C. Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial. CLINICAL LUNG CANCER 2011; 12(6): 407-411. Editorial Material. |
2,944 |
Q2 |
|
2011 |
Gómez-Raposo, C.; Mendiola, M.; Barriuso, J.; Hardisson, D.; Redondo, A. From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2011; 20(5): 591-594. Editorial Material. |
5,274 |
D1 |
|
2011 |
Oaknin, A.; Roda, D.; González-Martín, A.; Chiva, L.; García-Donas,
J.; de Juan, A.; Redondo, A.; Martínez, S.; García, Y.; Catot, S.; Ponce, J.; del Campo, J. M.; Cervantes, A.; Poveda, A. Feasibility of a Modified Outpatient Regimen of Intravenous/Intraperitoneal Chemotherapy in Optimally Debulked Stage III Ovarian Cancer Patients A GEICO Study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2011; 21(6): 1048-1055. Article. |
1,646 |
Q3 |
|
2011 |
Yap, T. A.; Olmos, D.; Brunetto, A. T.; Tunariu, N.; Barriuso, J.; Riisnaes,
R.; Pope, L.; Clark, J.; Futreal, A.; Germuska, M.; Collins, D.; Desouza, N. M.; Leach, M. O.; Savage, R. E.; Waghorne, C.; Chai, F.; Garmey, E.; Schwartz, B.; Kaye, S. B.; de Bono, J. S. Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies. JOURNAL OF CLINICAL ONCOLOGY. 2011; 29(10): 1271-1279. Article. |
18,372 |
D1 |
|
2011 |
Banz, K.; Bischoff, H.; Brunner, M.; Chouaid, C.; Carpeno, J. D.; de Marinis, F.; Grossi, F.; Vergnenegre, A.; Walzer, S. Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain. LUNG CANCER. 2011; 74(3): 529-534. Article. |
3,434 |
Q1 |
|
2011 |
Feliú, J.; Virizuela, J. A. Follow-up of cancer survivors: a shared responsibility. MEDICINA CLINICA. 2011; 137(4): 163-165. Editorial
Material. |
1,385 |
Q2 |
|
2011 |
Castellano, D.; Grande, E.; Barriuso, J. Advances in Pancreatic Neuroendocrine Tumor Treatment. NEW ENGLAND JOURNAL
OF MEDICINE. 2011; 364(19): 1872-1873. Letter. |
53,298 |
D1 |
|
2011 |
Goss, P. E.; Ingle, J. N.; Ales-Martínez, J. E.; Cheung, A. M.; Chlebowski,
R. T.; Wactawski-Wende, J.; McTiernan, A.; Robbins, J.; Johnson, K. C.; Martin, L. W.; Winquist, E.; Sarto, G. E.; Garber, J. E.; Fabián, C. J.; Pujol, P.; Maunsell, E.; Farmer, P.; Gelmon, K. A.; Tu, D.; Richardson, H. (Zamora, P.) Exemestane for Breast-Cancer Prevention in Postmenopausal Women. NEW ENGLAND JOURNAL OF MEDICINE. 2011; 364(25): 2381-2391. Article. |
53,298 |
D1 |
|
2011 |
Gómez-Candela, C.; Sanz, M. V.; Horrisberger, A.; Kohen, V. L.; Bermejo, L. M.; Auñón, P. Z. Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients. NUTRICIÓN HOSPITALARIA. 2011; 26(6): 1385-1393. Article. |
1,12 |
Q4 |
|
2011 |
Vega, B. R.; Palao, A.; Torres, G.; Hospital, A.; Benito, G.; Pérez, E.; Diéguez, M.; Castelo, B.; Bayón, C. Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial. PSYCHO-ONCOLOGY. 2011; 20(9): 943-952. Article. |
3,339 |
Q1 |
|
2011 |
Leskelä, S.; Leandro-García, L. J.; Mendiola, M.; Barriuso, J.; Inglada-
Pérez, L.; Muñoz, I.; Martínez-Delgado, B.; Redondo, A.; de Santiago, J.; Robledo, M.; Hardisson, D.; Rodríguez-Antona, C. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. ENDOCRINE RELATED CANCER. 2011; 18(1): 85-95. Article. |
4,364 |
Q1 |
|
2011 |
Pinto Marín, A.; Ballesteros García, A. I.; Izarzugaza Perón, Y.; Mansó Sánchez, L.; López-Tarruella Cobo, S.; Zamora Auñón, P. Adjuvant hormonal therapy in perimenopausal patients. ADVANCES IN THERAPY. 2011; 28(Suppl.6): 39-49. Review |
2,105 |
Q3 |
|
2010 |
de Cáceres, I. I.; Cortés-Sempere, M.; Moratilla, C.; Machado-Pinilla, R.; Rodríguez-Fanjul, V.; Manguán-García, C.; Cejas, P.; López-Ríos, F.; Paz-Ares, L.; de Castro Carpeño, J.; Nistal, M.; Belda-Iniesta, C.; Perona, R. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. ONCOGENE. 2010; 29(11): 1681-1690. Article. |
7,414 |
Q1
|
|
2010 |
Villaronga, M. A.; Lavery, D. N.; Bevan C. L.; Llanos, S.; Belandia, B. HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions. ONCOGENE. 2010; 21: 411-420. Article. |
7,414 |
Q1
|
|
2010 |
Sánchez-Navarro, I.; Gámez-Pozo, A.; González-Barón, M.; Pinto-Marin, A.; Hardisson, D.; López, R.; Madero, R.; Cejas, P.; Mendiola, M.; Espinosa, E.; Vara, J. A. F. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. BIOTECHNIQUES. 2010; 48(5): 389-396. Article. |
2,55 |
Q2
|
|
2010 |
Costero, O.; Picazo, M. L.; Zamora, P.; Romero, S.; Martínez-Ara, J.; Selgas, R. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010; 25(3): 1001-1003. Article. |
3,564 |
Q1
|
|
2010 |
Sánchez-Navarro, I.; Gámez-Pozo, A.; Pinto, A.; Hardisson, D.; Madero, R.; López, R.; Jose, B. S.; Zamora, P.; Redondo, A.; Feliu, J.; Cejas, P.; Barón, M. G.; Vara, J. A. F.; Espinosa, E. An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer. BMC CANCER. 2010; 10: 336. Article. |
3,153 |
Q2
|
|
2010 |
Espinosa, E.; Pinto, A.; Zamora, P.; Feliu, J.; Martínez, B.; Barón, M. G. Palliative care is a key component of daily practice in oncology: descriptive study of hospitalisation events at an oncology treatment centre. SUPPORTIVE CARE IN CANCER. 2010; 18(9): 1231-1234. Article. |
2,058 |
Q2
|
|
2010 |
Al-Saffar, N. M. S.; Jackson, L. E.; Raynaud, F. I.; Clarke, P. A.; de Molina, A. R.; Lacal, J. C.; Workman, P.; Leach, M. O. The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase a Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy. CANCER RESEARCH. 2010; 70(13): 5507-5517. Article.
|
8,234 |
Q1
|
|
2010 |
Pestaña, D.; Espinosa, E.; Sanguesa-Molina, J. R.; Ramos, R.; Pérez-Fernández, E.; Duque, M.; Martínez-Casanova, E. Compliance With a Sepsis Bundle and Its Effect on Intensive Care Unit Mortality in Surgical Septic Shock Patients. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2010; 69(5): 1282-1287. Article. |
3,129 |
Q1
|
|
2010 |
Marín, A. P.; Arranz, E. E.; Sánchez, A. R.; Auñón, P. Z; Barón, M. G. Role of anti-Her-2 therapy in bladder carcinoma. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2010; 136(12): 1915-1920. Article. |
2,485 |
Q3
|
|
2010 |
Feliú, J.; Safont, M. J.; Salud, A.; Losa, F.; García-Girón, C.; Bosch, C.; Escudero, P.; López, R.; Madronal, C.; Bolaños, M.; Gil, M.; Llombart, A.; Castro-Carpeño, J.; González-Barón, M. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer. BRITISH JOURNAL OF CANCER. 2010; 102(10): 1468-1473. Article. |
4,831 |
Q1
|
|
2010 |
Leskelä, S.; Leandro-García, L. J.; Mendiola, M.; Barriuso, J.; Inglada-Pérez, L.; Muñoz, I.; Martínez-Delgado, B.; Redondo, A.; de Santiago, J.; Robledo, M.; Hardisson, D.; Rodríguez-Antona, C. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. ENDOCRINE RELATED CANCER. 2010; 18(1): 85-95. Article. |
4,432. |
Q1
|
|
2010 |
Moreno-Rubio, J.; Herrero-Beaumont, G.; Tardio, L.; Álvarez-Soria, M. A.; Largo, R. Nonsteroidal Antiinflammatory Drugs and Prostaglandin E-2 Modulate the Synthesis of Osteoprotegerin and RANKL in the Cartilage of Patients With Severe Knee Osteoarthritis. ARTHRITIS AND RHEUMATISM. 2010; 62(2): 478-488. Article. |
8,435 |
Q1
|
|
2010 |
Largo, R.; Roman-Bias, J. A.; Moreno-Rubio, J.; Sánchez-Pernaute, O.; Martínez-Calatrava, M. J.; Castaneda, S.; Herrero-Beaumont, G. Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis. OSTEOARTHRITIS AND CARTILAGE. 2010; 18(Suppl. 1): S17-S23. Article. |
3,953 |
Q1
|
|
2010 |
Gómez-Raposo, C.; Mendiola, M.; Barriuso, J.; Hardisson, D.; Redondo, A. Molecular characterization of ovarian cancer by gene-expression profiling. GYNECOLOGIC ONCOLOGY. 2010; 118(1): 88-92. Review. |
3,76 |
Q1
|
|
2010 |
Pinto, A.; Redondo, A.; Zamora, P.; Castelo, B.; Espinosa, E. Angiogenesis as a therapeutic target in urothelial carcinoma. ANTI-CANCER DRUGS. 2010; 21(10): 890-896. Review. |
2,376 |
Q2
|
|
2010 |
Navarro, S.; Vaquero, E.; Maurel, J.; Bombi, J. A.; De Juan, C.; Feliu, J.; Cruz, L. F.; Ginés, A.; Girela, E.; Rodríguez, R.; Sabater, L. Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part I). MEDICINA CLÍNICA. 2010; 134(14): 643-655. Editorial Material. |
1,413 |
Q2
|
|
2010 |
Navarro, S.; Vaquero, E.; Maurel, J.; Bombi, J. A.; De Juan, C.; Feliu, J.; Cruz, L. F.; Ginés, A.; Girela, E.; Rodríguez, R.; Sabater, L. Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part II). MEDICINA CLÍNICA. 2010; 134(15): 692-702. Editorial Material. |
1,413 |
Q2
|
|
2009 |
Schadendorf, D; Algarra, SM; Bastholt, L; Cinat, G; Dreno, B; Eggermont, AMM; Espinosa, E; Guo, J; Hauschild, A; Petrella, T; Schachter, J; Hersey, P. Immunotherapy of distant metastatic disease. ANNALS OF ONCOLOGY. 2009; 20(Suppl. 6): 41-50 |
5,647 |
Q1
|
|
2009 |
Marin, AP; Sanchez, AR; Arranz, EE. Nasal septum perforation in a breast cancer patient treated with bevacizumab. ANNALS OF ONCOLOGY. 2009; 20(11): 1901-1902 |
5,647 |
Q1
|
|
2009 |
Hersey, P; Bastholt, L; Chiarion-Sileni, V; Cinat, G; Dummer, R; Eggermont, AMM; Espinosa, E; Hauschild, A; Quirt, I; Robert, C; Schadendorf, D. Small molecules and targeted therapies in distant metastatic disease. ANNALS OF ONCOLOGY. 2009; 20(Suppl. 6): 35-40 |
5,647 |
Q1
|
|
2009 |
Valdes-Mora, F; del Pulgar, TG; Bandres, E; Cejas, P; de Molina, AR; Perez-Palacios, R; Gallego-Ortega, D; Garcia-Cabezas, MA; Casado, E; Larrauri, J; Nistal, M; Gonzalez-Baron, M; Garcia-Foncillas, J; Lacal, J. TWIST1 Overexpression is Associated with Nodal Invasion and Male Sex in Primary Colorectal Cancer. ANNALS OF SURGICAL ONCOLOGY. 2009; 16(1): 78-87 |
4,130 |
Q1
|
|
2009 |
Castro-Carpeno,J. D.;Moyano,M. S.;Saenz,E. C.;Belda-Iniesta,C.;Batlle,J. F.;Baron,M. G.. WITHDRAWN:Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases. ANTICANCER DRUGS. 2009; 20 (Special Issue 1): S7-S10 |
2,230 |
Q3
|
|
2009 |
Belda-Iniesta,C.;Saenz,E. C.;de Castro-Carpeno,J.;Hernandez,E.;Baron,M. G.. WITHDRAWN:Complete and rapid response to FOLFIRI plus bevacizumab in a patient presenting with impaired liver function and poor performance status from colon cancer liver metastases. ANTICANCER DRUGS. 2009; 20 (Special Issue 1): S11-S12 |
2,230 |
Q3
|
|
2009 |
Sereno Moyano,M.;Casado Saenz,E.;de Castro-Carpeno,J.;Belda-Iniesta,C.. WITHDRAWN:The combination of FOLFOX4 and bevacizumab may enable salvage surgery of unresectable liver metastases in colon cancer. ANTICANCER DRUGS. 2009; 20 (Special Issue 1): S4-S6 |
2,230 |
Q3
|
|
2009 |
Barroso, E; Pita, G; Arias, JI; Menendez, P; Zamora, P; Blanco, M; Benitez, J; Ribas, G. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. BREAST CANCER RESEARCH AND TREATMENT. 2009; 118(3): 655-660 |
4,696 |
Q1
|
|
2009 |
Postel-Vinay, S; Arkenau, HT; Olmos, D; Ang, J; Barriuso, J; Ashley, S; Banerji, U; De-Bono, J; Judson, I; Kaye, S. Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?. BRITISH JOURNAL OF CANCER. 2009; 100(9): 1373-1378 |
4,346 |
Q1
|
|
2009 |
Feliu, J; Firvida, JL; Castro, J; Madronal, C; Rodriguez-Jaraiz, A; Salgado, M; Belda-Iniesta, C; Casado, E; Garcia-Mata, J; Gonzalez-Baron, M. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2009; 63(3): 403-409 |
2,654 |
Q2
|
|
2009 |
Cortes-Sempere, M; Chattopadhyay, S; Rovira, A; Rodriguez-Fanjul, V; Belda-Iniesta, C; Tapia, M; Cejas, P; Machado-Pinilla, R; Manguan-Garcia, C; Sanchez-Perez, I; Nistal, M; Moratilla, C; de Castro-Carpeno, J; Gonzalez-Baron, M; Albanell, J; Perona, R. MKP1 repression is required for the chemosensitizing effects of NF-kappa B and PI3K inhibitors to cisplatin in non-small cell lung cancer. CANCER LETTERS. 2009; 286(2): 206-216 |
3,741 |
Q2
|
|
2009 |
Feliu, J; Sereno, M; De Castro, J; Belda, C; Casado, E; Gonzalez-Baron, M. Chemotherapy for colorectal cancer in the elderly: Who to treat and what to use. CANCER TREATMENT REVIEWS. 2009; 35(3): 246-254 |
5,295 |
Q1
|
|
2009 |
Gomez-Raposo, C; Mendiola, M; Barriuso, J; Casado, E; Hardisson, D; Redondo, A. Angiogenesis and ovarian cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(9): 564-571 |
1,146 |
Q4
|
|
2009 |
Provencio, M; Garcia-Campelo, R; Isla, D; de Castro, J. Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors. CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(7): 428-436 |
1,146 |
Q4
|
|
2009 |
Hidalgo, M; Abad, A; Aranda, E; Diez, L; Feliu, J; Gomez, C; Irigoyen, A; Lopez, R; Rivera, F; Rubio, C; Sastre, J; Tabernero, J; Diaz-Rubio, E. Consensus on the treatment of pancreatic cancer in Spain. CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(5): 290-301 |
1,146 |
Q4
|
|
2009 |
Tusquets, I; Arranz, EE; Mendez, M; Gil, JM; Guallar, JL; Perulero, N. Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study). CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(4): 221-227 |
1,146 |
Q4
|
|
2009 |
Marin, AP; Arevalo, MG; Sanchez, AR; Arranz, EE; Aunon, PZ; Baron, MG. Intra-abdominal desmoplastic small round cell tumour in a 39-year-old man. CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(11): 770-772 |
1,146 |
Q4
|
|
2009 |
Marin, AP; Agudo, EH; Feliu, J; Baron, MG. Pancreatic glucagonoma presenting as a pulmonary mass. CLINICAL & TRANSLATIONAL ONCOLOGY. 2009; 11(1): 60-62 |
1,146 |
Q4
|
|
2009 |
M Mendiola, J Barriuso, D Hardisson.. Targeting Angiogenesis in Ovarian Carcinoma. CURRENT CANCER THERAPY REVIEWS. 2009; 5(): 188-202 |
No tiene |
No tiene
|
|
2009 |
Martin-Algarra, S; Espinosa, E; Rubio, J; Lopez, JJL; Manzano, JL; Carrion, LA; Plazaola, A; Tanovic, A; Paz-Ares, L. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma. EUROPEAN JOURNAL OF CANCER. 2009; 45(5): 732-735 |
4,121 |
Q2
|
|
2009 |
Mendiola, M; Barriuso, J; Marino-Enriquez, A; Redondo, A; Dominguez-Caceres, A; Hernandez-Cortes, G; Perez-Fernandez, E; Sanchez-Navarro, I; Vara, JAF; Suarez, A; Espinosa, E; Gonzalez-Baron, M; Palacios, J; Hardisson, D. Aurora kinases as prognostic biomarkers in ovarian carcinoma. HUMAN PATHOLOGY. 2009; 40(5): 631-638 |
2,961 |
Q2
|
|
2009 |
Garcia, VM; Cejas, P; Codesido, MB; Batlle, JF; Carpeno, JD; Belda-Iniesta, C; Barriuso, J; Sanchez, JJ; Larrauri, J; Gonzalez-Baron, M; Casado, E. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2009; 24(7): 741-748 |
2,102 |
Q2
|
|
2009 |
Arkenau, HT; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S. Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials. JOURNAL OF CLINICAL ONCOLOGY. 2009; 27(16): 2692-2696 |
17,793 |
Q1
|
|
2009 |
Marin, AP; Baron, MG. Superior vena cava syndrome. MEDICINA CLINICA. 2009; 132(5): 195-199 |
1,231 |
Q3
|
|
2009 |
Hernando, E; Sarmentero-Estrada, J; Koppie, T; Belda-Iniesta, C; de Molina, VR; Cejas, P; Ozu, C; Le, C; Sanchez, JJ; Gonzalez-Baron, M; Koutcher, J; Cordon-Cardo, C; Bochner, BH; Lacal, JC; de Molina, AR. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. ONCOGENE. 2009; 28(26): 2425-2435 |
7,135 |
Q1
|
|
2009 |
Arkenau, HT; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; Judson, I; Kaye, S. Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer. ONCOLOGY. 2009; 76(3): 151-156 |
2,112 |
Q3
|
|
2009 |
Sereno, M; De Castro, J; Belda-Iniesta, C; Garcia-Cabezas, MA; Cejas, P; Casado, E; Barriuso, J; Feliu, J; Larrauri, J. EPO-R Expression Patterns in Resected Gastric Adenocarcinoma Followed by Adjuvant Chemoradiation Treatment. PATHOLOGY & ONCOLOGY RESEARCH. 2009; 15(1): 1-10 |
1,152 |
Q4
|
|
2009 |
Espinosa, E; Sanchez-Navarro, I; Gamez-Pozo, A; Marin, AP; Hardisson, D; Madero, R; Redondo, A; Zamora, P; Valiente, BS; Mendiola, M; Baron, MG; Vara, JAF. Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer. PLOS ONE. 2009; 4(6): e5911 |
4,351 |
Q1
|
|
2009 |
Cejas, P; Lopez-Gomez, M; Aguayo, C; Madero, R; Carpeno, JD; Belda-Iniesta, C; Barriuso, J; Garcia, VM; Larrauri, J; Lopez, R; Casado, E; Gonzalez-Baron, M; Feliu, J. KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis. PLOS ONE. 2009; 4(12): e8199 |
4,351 |
Q1
|
|
2009 |
Gamez-Pozo, A; Sanchez-Navarro, I; Nistal, M; Calvo, E; Madero, R; Diaz, E; Camafeita, E; de Castro, J; Lopez, JA; Gonzalez-Baron, M; Espinosa, E; Vara, JAF. MALDI Profiling of Human Lung Cancer Subtypes. PLOS ONE. 2009; 4(11): e7731 |
4,351 |
Q1
|
|
2009 |
Marin, AP; Sanchez, AR; Arranz, EE; Aunon, PZ; Baron, MG. Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment. SOUTHERN MEDICAL JOURNAL. 2009; 102(9): 929-934 |
0,924 |
Q3
|
|
2009 |
Jimenez-Gordo, A; Feliu, J; Martinez, B; de-Castro, J; Rodriguez-Salas, N; Sastre, N; Vilches, Y; Espinosa, E; Rodriguez-Aizcorbe, J; Gonzalez-Baron, M. Descriptive analysis of clinical factors affecting terminally ill cancer patients. SUPPORTIVE CARE IN CANCER. 2009; 17(3): 261-269 |
2,089 |
Q1
|
|